547 results on '"Chadwick D. Miller"'
Search Results
2. Prehospital Time Disparities for Rural Patients with Suspected STEMI
- Author
-
Jason P. Stopyra, Remle P. Crowe, Anna C. Snavely, Michael W. Supples, Nathan Page, Zachary Smith, Nicklaus P. Ashburn, Kristie Foley, Chadwick D. Miller, and Simon A. Mahler
- Subjects
Emergency Medicine ,Emergency Nursing - Abstract
Rural patients with ST-elevation myocardial infarction (STEMI) may be less likely to receive prompt reperfusion therapy. This study's primary objective was to compare rural versus urban time intervals among a national cohort of prehospital patients with STEMI.The ESO Data Collaborative (Austin, TX), containing records from 1,366 emergency medical services agencies, was queried for adult 9-1-1 responses with suspected STEMI from 1/1/2018-12/31/2019. The scene address for each encounter was classified as either urban or rural using the 2010 US Census Urban Area Zip Code Tabulation Area relationship. The primary outcome was total EMS interval (9-1-1 call to hospital arrival); a key secondary outcome was the proportion of responses that had EMS intervals under 60 minutes. Generalized estimating equations were used to determine whether rural versus urban differences in interval outcomes occurred when adjusting for loaded mileage (distance from scene to hospital) and patient and clinical encounter characteristics.Of 15,915,027 adult 9-1-1 transports, 23,655 records with suspected STEMI were included in the analysis. Most responses (91.6%, n = 21,661) occurred in urban settings. Median EMS interval was 37.6 minutes (IQR 30.0-48.0) in urban settings compared to 57.0 minutes (IQR 46.5-70.7) in rural settings (p 0.01). Urban responses more frequently had EMS intervals60 minutes (89.5%, n = 19,130), compared to rural responses (55.5%, n = 1,100, p 0.01). After adjusting for loaded mileage, age, sex, race/ethnicity, abnormal vital signs, pain assessment, aspirin administration, and IV/IO attempt, rural location was associated with a 5.8 (95%CI 4.2-7.4) minute longer EMS interval than urban, and rural location was associated with a reduced chance of achieving EMS interval60 minutes (OR 0.40; 95%CI 0.33-0.49) as compared to urban location.In this large national sample, rural location was associated with significantly longer EMS interval for patients with suspected STEMI, even after accounting for loaded mileage.
- Published
- 2022
3. Prehospital time for patients with acute cardiac complaints: A rural health disparity
- Author
-
Anna C. Snavely, Remle P. Crowe, Henderson D. McGinnis, Chadwick D. Miller, Ryan M. Angi, Jason P. Stopyra, Brian Hiestand, Simon A. Mahler, Nicklaus P. Ashburn, and James F. Scheidler
- Subjects
Male ,Rural Population ,Emergency Medical Services ,medicine.medical_specialty ,Transport time ,Article ,Time-to-Treatment ,Primary outcome ,Humans ,Medicine ,Healthcare Disparities ,Generalized estimating equation ,Aged ,Retrospective Studies ,Cardiac problems ,business.industry ,Rural health ,General Medicine ,Middle Aged ,United States ,Cross-Sectional Studies ,Cardiovascular Diseases ,Acute Disease ,Emergency medicine ,Emergency Medicine ,Female ,business - Abstract
Objective Delays in care for patients with acute cardiac complaints are associated with increased morbidity and mortality. The objective of this study was to quantify rural and urban differences in prehospital time intervals for patients with cardiac complaints. Methods The ESO Data Collaborative dataset consisting of records from 1332 EMS agencies was queried for 9–1-1 encounters with acute cardiac problems among adults (age ≥ 18) from 1/1/2013–6/1/2018. Location was classified as rural or urban using the 2010 United States Census. The primary outcome was total prehospital time. Generalized estimating equations evaluated differences in the average times between rural and urban encounters while controlling for age, sex, race, transport mode, loaded mileage, and patient stability. Results Among 428,054 encounters, the median age was 62 (IQR 50–75) years with 50.7% female, 75.3% white, and 10.3% rural. The median total prehospital, response, scene, and transport times were 37.0 (IQR 29.0–48.0), 6.0 (IQR 4.0–9.0), 16.0 (IQR 12.0–21.0), and 13.0 (IQR 8.0–21.0) minutes. Rural patients had an average total prehospital time that was 16.76 min (95%CI 15.15–18.38) longer than urban patients. After adjusting for covariates, average total time was 5.08 (95%CI 4.37–5.78) minutes longer for rural patients. Average response and transport time were 4.36 (95%CI 3.83–4.89) and 0.62 (95%CI 0.33–0.90) minutes longer for rural patients. Scene time was similar in rural and urban patients (0.09 min, 95%CI -0.15-0.33). Conclusion Rural patients with acute cardiac complaints experienced longer prehospital time than urban patients, even after accounting for other key variables, such as loaded mileage.
- Published
- 2022
4. Prehospital Translation of Chest Pain Tools (RESCUE Study): Completion Rate and Inter-rater Reliability
- Author
-
Anna C, Snavely, Simon A, Mahler, Nella W, Hendley, Nicklaus P, Ashburn, Brian, Hehl, Jordan, Vorrie, Matthew, Wells, R Darrel, Nelson, Chadwick D, Miller, and Jason P, Stopyra
- Subjects
Adult ,Male ,Chest Pain ,Emergency Medical Services ,Emergency Medicine ,Humans ,Reproducibility of Results ,Female ,Prospective Studies ,General Medicine ,Acute Coronary Syndrome ,Middle Aged - Abstract
Introduction: Chest pain is a common reason for ambulance transport. Acute coronary syndrome (ACS) and pulmonary embolism (PE) risk assessments, such as history, electrocardiogram, age, risk factors (HEAR); Emergency Department Assessment of Chest Pain Score (EDACS); Pulmonary Embolism Rule-out Criteria (PERC); and revised Geneva score, are well validated for emergency department (ED) use but have not been translated to the prehospital setting. The objectives of this study were to evaluate the 1) prehospital completion rate and 2) inter-rater reliability of chest pain risk assessments. Methods: We conducted a prospective observational cohort study in two emergency medical services (EMS) agencies (April 18, 2018 – January 2, 2019). Adults with acute, non-traumatic chest pain without ST-elevation myocardial infarction or unstable vital signs were accrued. Paramedics were trained to use the HEAR, EDACS, PERC, and revised Geneva score assessments. A subset of patients (a priori goal of N = 250) also had the four risk assessments completed by their treating clinicians in the ED, who were blinded to the EMS risk assessments. Outcomes were 1) risk assessments completion rate and 2) inter-rater reliability between EMS and ED assessments. An a priori goal for completion rate was set as >75%. We computed kappa with corresponding 95% confidence intervals (CI) for each risk assessment as a measure of inter-rater reliability. Acceptable agreement was defined a priori as kappa ≥ 0.60. Results: During the study period, 837 patients with acute chest pain were accrued. The median age was 54 years, interquartile range 43-66, with 53% female and 51% Black. Completion rates for each risk assessment were above goal: the HEAR score was completed on 95.1% (796/837), EDACS on 92.0% (770/837), PERC on 89.4% (748/837), and revised Geneva score on 90.7% (759/837) of patients. We assessed agreement in a subgroup of 260 patients. The HEAR score had a kappa of 0.51 (95% CI, 0.41- 0.61); EDACS was 0.60 (95% CI, 0.49-0.72); PERC was 0.71 (95% CI, 0.61-0.81); and revised Geneva score was 0.51 (95% CI, 0.39-0.62). Conclusion: The completion rate of risk assessments for ACS and PE was high for prehospital field personnel. The PERC and EDACS both demonstrated acceptable agreement between paramedics and clinicians in the ED, although assessments with better agreement are likely needed.
- Published
- 2022
5. EMS blood collection from patients with acute chest pain reduces emergency department length of stay
- Author
-
Evan L. McMurray, R. Darrell Nelson, Nicklaus P. Ashburn, Meagan R. Hunt, Simon A. Mahler, Jason P. Stopyra, Chadwick D. Miller, and Anna C. Snavely
- Subjects
Adult ,Male ,Chest Pain ,Emergency Medical Services ,medicine.medical_specialty ,Acute coronary syndrome ,Myocardial Infarction ,Chest pain ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Single-Blind Method ,Prospective Studies ,Myocardial infarction ,Aged ,biology ,business.industry ,030208 emergency & critical care medicine ,General Medicine ,Overcrowding ,Emergency department ,Length of Stay ,Middle Aged ,medicine.disease ,Troponin ,Emergency medicine ,Emergency Medicine ,biology.protein ,Female ,medicine.symptom ,business ,Mace ,Cohort study - Abstract
Background Expediting the measurement of serum troponin by leveraging EMS blood collection could reduce the diagnostic time for patients with acute chest pain and help address Emergency Department (ED) overcrowding. However, this practice has not been examined among an ED chest pain patient population in the United States. Methods A prospective observational cohort study of adults with non-traumatic chest pain without ST-segment elevation myocardial infarction was conducted in three EMS agencies between 12/2016–4/2018. During transport, paramedics obtained a patient blood sample that was sent directly to the hospital core lab for troponin measurement. On ED arrival HEART Pathway assessments were completed by ED providers as part of standard care. ED providers were blinded to troponin results from EMS blood samples. To evaluate the potential impact on length of stay (LOS), the time difference between EMS blood draw and first clinical ED draw was calculated. To determine the safety of using troponin measures from EMS blood samples, the diagnostic performance of the HEART Pathway for 30-day major adverse cardiac events (MACE: composite of cardiac death, myocardial infarction (MI), coronary revascularization) was determined using EMS troponin plus arrival ED troponin and EMS troponin plus a serial 3-h ED troponin. Results The use of EMS blood samples for troponin measures among 401 patients presenting with acute chest pain resulted in a mean potential reduction in LOS of 72.5 ± SD 35.7 min. MACE at 30 days occurred in 21.0% (84/401), with 1 cardiac death, 78 MIs, and 5 revascularizations without MI. Use of the HEART Pathway with EMS and ED arrival troponin measures yielded a NPV of 98.0% (95% CI: 89.6–100). NPV improved to 100% (95% CI: 92.9–100) when using the EMS and 3-h ED troponin measures. Conclusions EMS blood collection used for core lab ED troponin measures could significantly reduce ED LOS and appears safe when integrated into the HEART Pathway.
- Published
- 2021
6. Sex and race differences in safety and effectiveness of the HEART pathway accelerated diagnostic protocol for acute chest pain
- Author
-
Simon A. Mahler, Kristin M. Lenoir, Jason P. Stopyra, Anna C. Snavely, Nella W. Hendley, Brian J. Wells, Chadwick D. Miller, Brian Hiestand, and David M. Herrington
- Subjects
Adult ,Male ,Chest Pain ,medicine.medical_specialty ,Acute coronary syndrome ,Myocardial Infarction ,Subgroup analysis ,030204 cardiovascular system & hematology ,Chest pain ,Logistic regression ,White People ,Article ,Decision Support Techniques ,03 medical and health sciences ,Sex Factors ,0302 clinical medicine ,Internal medicine ,Ethnicity ,North Carolina ,Odds Ratio ,medicine ,Acute chest pain ,Humans ,030212 general & internal medicine ,Myocardial infarction ,Acute Coronary Syndrome ,Mortality ,Aged ,business.industry ,Hispanic or Latino ,Emergency department ,Middle Aged ,medicine.disease ,Health equity ,Black or African American ,Hospitalization ,Logistic Models ,Female ,medicine.symptom ,Emergency Service, Hospital ,Cardiology and Cardiovascular Medicine ,business - Abstract
BACKGROUND: The HEART Pathway is an accelerated diagnostic protocol for Emergency Department patients with possible acute coronary syndrome. The objective was to compare the safety and effectiveness of the HEART Pathway among women vs men and whites vs non-whites. METHODS: A subgroup analysis of the HEART Pathway Implementation Study was conducted. Adults with chest pain were accrued from November 2013 to January 2016 from 3 Emergency Departments in North Carolina. The primary outcomes were death and myocardial infarction (MI) and hospitalization rates at 30 days. Logistic regression evaluated for interactions of accelerated diagnostic protocol implementation with sex or race and changes in outcomes within subgroups. RESULTS: A total of 8,474 patients were accrued, of which 53.6% were female and 34.0% were non-white. The HEART Pathway identified 32.6% of females as low-risk vs 28.5% of males (P = 002) and 35.6% of non-whites as low-risk vs 28.0% of whites (P < .0001). Among low-risk patients, death or MI at 30 days occurred in 0.4% of females vs 0.5% of males (P = .70) and 0.5% of non-whites vs 0.3% of whites (P = .69). Hospitalization at 30 days was reduced by 6.6% in females (aOR: 0.74, 95% CI: 0.64–0.85), 5.1% in males (aOR: 0.87, 95% CI: 0.75–1.02), 8.6% in non-whites (aOR: 0.72, 95% CI: 0.60–0.86), and 4.5% in whites (aOR: 0.83, 95% CI: 0.73–0.94). Interactions were not significant. CONCLUSION: Women and non-whites are more likely to be classified as low-risk by the HEART Pathway. HEART Pathway implementation is associated with decreased hospitalizations and a very low death and MI rate among low-risk patients regardless of sex or race.
- Published
- 2021
7. Identification of very low-risk acute chest pain patients without troponin testing
- Author
-
Simon A. Mahler, Brian Hiestand, Kristin M. Lenoir, Chadwick D. Miller, Jason P. Stopyra, Anna C. Snavely, Lane M. Smith, David M. Herrington, Brian J. Wells, and Nicklaus P. Ashburn
- Subjects
Adult ,Male ,Chest Pain ,EMX2 ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,Risk Assessment ,Sensitivity and Specificity ,Article ,Diagnosis, Differential ,03 medical and health sciences ,0302 clinical medicine ,Posterior commissure ,Predictive Value of Tests ,North Carolina ,medicine ,Humans ,030212 general & internal medicine ,Axon ,Transcription factor ,business.industry ,General Medicine ,Middle Aged ,Spinal cord ,Troponin ,United States ,medicine.anatomical_structure ,Acute Disease ,Emergency Medicine ,Homeobox ,Female ,Ectopic expression ,PAX6 ,business ,Neuroscience ,Biomarkers - Abstract
BackgroundThe HEART Pathway combines a History ECG Age Risk factor (HEAR) score and serial troponins to risk stratify patients with acute chest pain. However, it is unclear whether patients with HEAR scores of <1 require troponin testing. The objective of this study is to measure the major adverse cardiac event (MACE) rate among patients with <1 HEAR scores and determine whether serial troponin testing is needed to achieve a miss rate MethodsA secondary analysis of the HEART Pathway Implementation Study was conducted. HEART Pathway risk assessments (HEAR scores and serial troponin testing at 0 and 3 hours) were completed by the providers on adult patients with chest pain from three US sites between November 2014 and January 2016. MACE (composite of death, myocardial infarction (MI) and coronary revascularisation) at 30 days was determined. The proportion of patients with HEAR scores of <1 diagnosed with MACE within 30 days was calculated. The impact of troponin testing on patients with HEAR scores of <1 was determined using Net Reclassification Improvement Index (NRI).ResultsProviders completed HEAR assessments on 4979 patients and HEAR scores<1 was 97.8% (95%CI 94.5% to 99.4%) and 99.1% (95% CI 97.7% to 99.8%), respectively, and were not improved by troponin testing. Troponin testing in patients with HEAR <1 correctly reclassified two patients diagnosed with MACE, and was elevated among seven patients without MACE yielding an NRI of 0.9% (95%CI −0.7 to 2.4%).ConclusionThese data suggest that patients with HEAR scores of 0 and 1 represent a very low-risk group that may not require troponin testing to achieve a missed MACE rate Trial registration numberNCT02056964
- Published
- 2020
8. Comparison of accelerated diagnostic pathways for acute chest pain risk stratification
- Author
-
Nella W. Hendley, David M. Herrington, Nicklaus P. Ashburn, Kristin M. Lenoir, Brian J. Wells, Brian Hiestand, Chadwick D. Miller, Anna C. Snavely, Simon A. Mahler, and Jason P. Stopyra
- Subjects
Male ,Time Factors ,Myocardial Infarction ,Comorbidity ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Chest pain ,Electrocardiography ,0302 clinical medicine ,Prospective Studies ,Myocardial infarction ,Prospective cohort study ,Aged, 80 and over ,Age Factors ,Middle Aged ,Prognosis ,Troponin ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Risk assessment ,Cohort study ,Adult ,Chest Pain ,Acute coronary syndrome ,medicine.medical_specialty ,Adolescent ,Clinical Decision-Making ,Risk Assessment ,Article ,Angina Pectoris ,Young Adult ,03 medical and health sciences ,Sex Factors ,Predictive Value of Tests ,Clinical Decision Rules ,North Carolina ,medicine ,Humans ,Acute Coronary Syndrome ,Risk factor ,Aged ,business.industry ,030208 emergency & critical care medicine ,Emergency department ,medicine.disease ,Heart Disease Risk Factors ,Emergency medicine ,business ,Biomarkers - Abstract
BackgroundThe History Electrocardiogram Age Risk factor Troponin (HEART) Pathway and Emergency Department Assessment of Chest pain Score (EDACS) are validated accelerated diagnostic pathways designed to risk stratify patients presenting to the emergency department with chest pain. Data from large multisite prospective studies comparing these accelerated diagnostic pathways are limited.MethodsThe HEART Pathway Implementation is a prospective three-site cohort study, which accrued adults with symptoms concerning for acute coronary syndrome. Physicians completed electronic health record HEART Pathway and EDACS risk assessments on participants. Major adverse cardiac events (death, myocardial infarction and coronary revascularisation) at 30 days were determined using electronic health record, insurance claims and death index data. Test characteristics for detection of major adverse cardiac events were calculated for both accelerated diagnostic pathways and McNemar’s tests were used for comparisons.Results5799 patients presenting to the emergency department were accrued, of which HEART Pathway and EDACS assessments were completed on 4399. Major adverse cardiac events at 30 days occurred in 449/4399 (10.2%). The HEART Pathway identified 38.4% (95% CI 37.0% to 39.9%) of patients as low-risk compared with 58.1% (95% CI 56.6% to 59.6%) identified as low-risk by EDACS (pConclusionsEDACS identifies a larger proportion of patients as low-risk than the HEART Pathway, but has a higher missed major adverse cardiac events rate at 30 days. Physicians will need to consider their risk tolerance when deciding whether to adopt the HEART Pathway or EDACS accelerated diagnostic pathway.Trial registration numberNCT02056964.
- Published
- 2020
9. Point-of-Care Troponin Testing during Ambulance Transport to Detect Acute Myocardial Infarction
- Author
-
Chadwick D. Miller, Jason P. Stopyra, James E. Winslow, Nicklaus P. Ashburn, Lauren E. Koehler, Gregory J. Pomper, James F. Scheidler, Robert F. Riley, Robert D Nelson, Simon A. Mahler, Nella W. Hendley, Lane M. Smith, and Anna C. Snavely
- Subjects
Adult ,Emergency Medical Services ,medicine.medical_specialty ,Ambulances ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Emergency Nursing ,Chest pain ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Prospective Studies ,Myocardial infarction ,Point of care ,biology ,business.industry ,030208 emergency & critical care medicine ,Emergency department ,medicine.disease ,Troponin ,Transportation of Patients ,Point-of-Care Testing ,Emergency medicine ,Emergency Medicine ,biology.protein ,medicine.symptom ,Ambulance transport ,business ,Biomarkers - Abstract
Objective: Use of point-of-care (POC) troponin (cTn) testing in the Emergency Department (ED) is well established. However, data examining POC cTn measurement in the prehospital setting, during amb...
- Published
- 2020
10. Monocyte chemoattractant protein-1 is not predictive of cardiac events in patients with non-low-risk chest pain
- Author
-
Nicklaus P Ashburn, Anna C Snavely, Brandon R Allen, Robert H Christenson, David M Herrington, Brian C Hiestand, Chadwick D Miller, Jason P Stopyra, and Simon A Mahler
- Subjects
Adult ,Chest Pain ,General Medicine ,Critical Care and Intensive Care Medicine ,Risk Assessment ,Article ,Troponin ,Predictive Value of Tests ,Risk Factors ,Case-Control Studies ,Emergency Medicine ,Humans ,Prospective Studies ,Emergency Service, Hospital ,Chemokine CCL2 - Abstract
BackgroundPrior studies suggest monocyte chemoattractant protein-1 (MCP-1) may be useful for risk stratifying ED patients with chest pain. We hypothesise that MCP-1 will be predictive of 90-day major adverse cardiovascular events (MACEs) in non-low-risk patients.MethodsA case–control study was nested within a prospective multicentre cohort (STOP-CP), which enrolled adult patients being evaluated for acute coronary syndrome at eight US EDs from 25 January 2017 to 06 September 2018. Patients with a History, ECG, Age, and Risk factor score (HEAR score) ≥4 or coronary artery disease (CAD), a non-ischaemic ECG, and non-elevated contemporary troponins at 0 and 3 hours were included. Cases were patients with 90-day MACE (all-cause death, myocardial infarction or revascularisation). Controls were patients without MACE selected with frequency matching using age, sex, race, and HEAR score or the presence of CAD. Serum MCP-1 was measured. Sensitivity and specificity were determined for cut-off points of 194 pg/mL, 200 pg/mL, 238 pg/mL and 281 pg/mL. Logistic regression adjusting for age, sex, race, and HEAR score/presence of CAD was used to determine the association between MCP-1 and 90-day MACE. A separate logistic model also included high-sensitivity troponin (hs-cTnT).ResultsAmong 40 cases and 179 controls, there was no difference in age (p=0.90), sex (p=1.00), race (p=0.85), or HEAR score/presence of CAD (p=0.89). MCP-1 was similar in cases (median 191.9 pg/mL, IQR: 161.8–260.1) and controls (median 196.6 pg/mL, IQR: 163.0–261.1) (p=0.48). At a cut-off point of 194 pg/mL, MCP-1 was 50.0% (95% CI 33.8% to 66.2%) sensitive and 46.9% (95% CI 39.4% to 54.5%) specific for 90-day MACE. After adjusting for covariates, MCP-1 was not associated with 90-day MACE at any cut-off point (at 194 pg/mL, OR 0.88 (95% CI 0.43 to 1.79)). When including hs-cTnT in the model, MCP-1 was not associated with 90-day MACE at any cut-off point (at 194 pg/mL, OR 0.85 (95% CI 0.42 to 1.73)).ConclusionMCP-1 is not predictive of 90-day MACE in patients with non-low-risk chest pain.
- Published
- 2021
11. Variability in sedation assessment among intubated patients in the emergency department
- Author
-
Ellen Caldwell, Catherine L. Hough, Chadwick D. Miller, Tessa L. Steel, Sharukh Lokhandwala, Nicholas J. Johnson, and Michelle N. Gong
- Subjects
Mechanical ventilation ,medicine.medical_specialty ,Sedation assessment ,business.industry ,Sedation ,medicine.medical_treatment ,Conscious Sedation ,General Medicine ,Emergency department ,Respiration, Artificial ,Article ,Respiratory failure ,Emergency medicine ,Emergency Medicine ,Medicine ,Humans ,Hypnotics and Sedatives ,medicine.symptom ,business ,Emergency Service, Hospital - Published
- 2021
12. Safely Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge
- Author
-
David M. Herrington, L. Douglas Case, Gregory L. Burke, Brian Hiestand, Jose-Franck Diaz-Garelli, Simon A. Mahler, Chadwick D. Miller, Brian J. Wells, Pamela W. Duncan, Wendell M. Futrell, and Kristin M. Lenoir
- Subjects
Male ,Chest Pain ,medicine.medical_specialty ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Article ,Electrocardiography ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Physiology (medical) ,Odds Ratio ,Acute chest pain ,Humans ,Medicine ,Prospective Studies ,Acute Coronary Syndrome ,Early discharge ,Aged ,biology ,business.industry ,Age Factors ,030208 emergency & critical care medicine ,Emergency department ,Middle Aged ,Troponin ,Patient Discharge ,Hospitalization ,Emergency medicine ,biology.protein ,Female ,Emergency Service, Hospital ,Cardiology and Cardiovascular Medicine ,business ,Algorithms - Abstract
Background: The HEART Pathway (history, ECG, age, risk factors, and initial troponin) is an accelerated diagnostic protocol designed to identify low-risk emergency department patients with chest pain for early discharge without stress testing or angiography. The objective of this study was to determine whether implementation of the HEART Pathway is safe (30-day death and myocardial infarction rate Methods: A prospective pre-post study was conducted at 3 US sites among 8474 adult emergency department patients with possible acute coronary syndrome. Patients included were ≥21 years old, investigated for possible acute coronary syndrome, and had no evidence of ST-segment–elevation myocardial infarction on ECG. Accrual occurred for 12 months before and after HEART Pathway implementation from November 2013 to January 2016. The HEART Pathway accelerated diagnostic protocol was integrated into the electronic health record at each site as an interactive clinical decision support tool. After accelerated diagnostic protocol integration, ED providers prospectively used the HEART Pathway to identify patients with possible acute coronary syndrome as low risk (appropriate for early discharge without stress testing or angiography) or non-low risk (appropriate for further in-hospital evaluation). The primary safety and effectiveness outcomes, death, and myocardial infarction (MI) and hospitalization rates at 30 days were determined from health records, insurance claims, and death index data. Results: Preimplementation and postimplementation cohorts included 3713 and 4761 patients, respectively. The HEART Pathway identified 30.7% as low risk; 0.4% of these patients experienced death or MI within 30 days. Hospitalization at 30 days was reduced by 6% in the postimplementation versus preimplementation cohort (55.6% versus 61.6%; adjusted odds ratio, 0.79; 95% CI, 0.71–0.87). During the index visit, more MIs were detected in the postimplementation cohort (6.6% versus 5.7%; adjusted odds ratio, 1.36; 95% CI, 1.12–1.65). Rates of death or MI during follow-up were similar (1.1% versus 1.3%; adjusted odds ratio, 0.88; 95% CI, 0.58–1.33). Conclusions: HEART Pathway implementation was associated with decreased hospitalizations, increased identification of index visit MIs, and a very low death and MI rate among low-risk patients. These findings support use of the HEART Pathway to identify low-risk patients who can be safely discharged without stress testing or angiography. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique identifier: NCT02056964.
- Published
- 2018
13. The Impact of Accelerated Diagnostic Protocol Implementation on Chest Pain Observation Unit Utilization
- Author
-
Simon A. Mahler, Brian Hiestand, Jason P. Stopyra, Chadwick D. Miller, and Iltifat Husain
- Subjects
medicine.medical_specialty ,Chest Pain ,Myocardial Infarction ,Chest pain ,Article ,Clinical Observation Units ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,biology ,Adult patients ,business.industry ,Background data ,Middle Aged ,medicine.disease ,Troponin ,Hospitalization ,Mann–Whitney U test ,biology.protein ,Registry data ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Emergency Service, Hospital ,Observation unit - Abstract
BACKGROUND: Data evaluating the impact of the history, ECG, age, risk factors, and troponin (HEART) Pathway on observation unit (OU) use is limited. The objective of this study is to determine how HEART Pathway implementation affects OU use. METHODS: An analysis of OU registry data from October 2012 to October 2016, 2 years before and after HEART Pathway implementation at an academic medical center, was conducted. Adult patients placed in the OU for chest pain were included. The proportion of patients placed in the OU chest pain protocol per total OU volume and hospitalization and myocardial infarction (MI) rates were determined. Proportions before versus after implementation were compared using χ(2) tests and age was compared using a Mann-Whitney U test. RESULTS: During the study period, 1688 patients with chest pain before HEART Pathway implementation and 1692 after were included. The proportion of chest pain patients in the OU per total OU volume decreased following implementation from (57% [1688/2968] to 43.6% [1692/3882]; P < 0.001). Before HEART Pathway implementation, the hospitalization rate was 10.4% (175/1688) versus 12.4% (210/1692) after (P = 0.07). More patients were diagnosed with MI following implementation (0.8% [14/1665] vs. 2.0% [33/1686]; P = 0. 008). Median age was older postimplementation (52 years [IQR: 45–59 years] vs. 54 years [IQR: 48–64 years]; P < 0. 001). CONCLUSIONS: HEART Pathway implementation resulted in management of higher risk patients in the OU. Following implementation, OU chest pain patients were older and were more likely to be hospitalized or diagnosed with MI.
- Published
- 2021
14. Abstract 12667: Racial Disparities in Emergency Care of Patients With Suspected ACS Undergoing Cardiac CT Angiography: Insights From Romicat II and ACRIN-PA
- Author
-
Harjit Singh, Michael T. Lu, James Uldeson, Travis R. Hallett, Harold Litt, Udo Hoffmann, Anna Chang, Fabian Bamberg, Sumbal A Janjua, Judd E. Hollander, Chadwick D. Miller, Daniel O. Bittner, Pamela K. Woodard, Thomas Mayrhofer, Daniel Addison, Christopher L. Schlett, Quynh A. Truong, John T. Nagurney, and Maros Ferencik
- Subjects
Coronary artery disease ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Physiology (medical) ,Internal medicine ,Angiography ,Cardiology ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease ,Health outcomes - Abstract
Introduction: A disparity in health outcomes between black and white patients with coronary artery disease (CAD) has also been reported with pathophysiological differences in CAD and racial disparities in providing health care as potential explanations. Hypothesis: To determine racial disparity in emergency care of patients with suspected acute coronary syndrome (ACS) undergoing cardiac CT angiography (cCTA), which provides knowledge of underlying CAD status. Methods: We combined patient level data of the ACRIN-PA 4005 (American College of Radiology Imaging Network, Pennsylvania) and ROMICAT II (Rule Out Myocardial Infarction using Computer Assisted Tomography) trials, which enrolled patients presenting with suspicion of ACS who were randomized to cCTA as a first diagnostic test at 14 US sites. Sample was restricted to subjects with known CAD status based on cCTA. Self-reported race while the race ‘Black’ were defined as “a person having origins in any of the black racial groups of Africa” and the race ‘white’ as “a person having origins in any of the original peoples of Europe, the Middle East, or North Africa”. Results: We included 1,191 patients (53% white, 47% black). Pretest probability for ACS was similar (TIMI score, p=0.77) between black and white patients, while black patients had lower presence and extent of CAD (calcium score: 39.3±189.3 vs. 88.2±292.1, p Conclusions: After adjustment for underlying CAD, among patients in the ED with suspicion of ACS, those who are black received more downstream testing and were more frequently admitted to hospital than white patients.
- Published
- 2020
15. HEART Pathway Implementation Safely Reduces Hospitalizations at One Year in Patients With Acute Chest Pain
- Author
-
Brian J. Wells, Kristin M. Lenoir, Jason P. Stopyra, Chadwick D. Miller, Anna C. Snavely, Brian Hiestand, Simon A. Mahler, and David M. Herrington
- Subjects
Acute coronary syndrome ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,030208 emergency & critical care medicine ,Odds ratio ,Emergency department ,medicine.disease ,Confidence interval ,Article ,03 medical and health sciences ,0302 clinical medicine ,Emergency medicine ,Cohort ,Emergency Medicine ,Medicine ,030212 general & internal medicine ,Myocardial infarction ,business ,Prospective cohort study ,Electrocardiography - Abstract
Study objective We determine whether implementation of the HEART (History, ECG, Age, Risk Factors, Troponin) Pathway is safe and effective in emergency department (ED) patients with possible acute coronary syndrome through 1 year of follow-up. Methods A preplanned analysis of 1-year follow-up data from a prospective pre-post study of 8,474 adult ED patients with possible acute coronary syndrome from 3 US sites was conducted. Patients included were aged 21 years or older, evaluated for possible acute coronary syndrome, and without ST-segment elevation myocardial infarction. Accrual occurred for 12 months before and after HEART Pathway implementation, from November 2013 to January 2016. The HEART Pathway was integrated into the electronic health record at each site as an interactive clinical decision support tool. After integration, ED providers prospectively used the HEART Pathway to identify patients with possible acute coronary syndrome as low risk (appropriate for early discharge without stress testing or angiography) or nonlow risk (appropriate for further inhospital evaluation). Safety (all-cause death and myocardial infarction) and effectiveness (hospitalization) at 1 year were determined from health records, insurance claims, and death index data. Results Preimplementation and postimplementation cohorts included 3,713 and 4,761 patients, respectively. The HEART Pathway identified 30.7% of patients as low risk; 97.5% of them were free of death and myocardial infarction within 1 year. Hospitalization at 1 year was reduced by 7.0% in the postimplementation versus preimplementation cohort (62.1% versus 69.1%; adjusted odds ratio 0.70; 95% confidence interval 0.63 to 0.78). Rates of death or myocardial infarction at 1 year were similar (11.6% versus 12.4%; adjusted odds ratio 1.00; 95% confidence interval 0.87 to 1.16). Conclusion HEART Pathway implementation was associated with decreased hospitalizations and low adverse event rates among low-risk patients at 1-year follow-up.
- Published
- 2020
16. Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events
- Author
-
R. David Harris, James E. Winslow, Lane M. Smith, Louis Fornage, Roy L. Alson, Nella W. Hendley, Lauren E. Koehler, David Conner, Jason P. Stopyra, Tyler Woodrum, Robert F. Riley, Simon A. Mahler, Jeremiah D. Gaddy, Anna C. Snavely, Gregory J. Pomper, Nicklaus P. Ashburn, Manrique Alvarez, Chadwick D. Miller, Adam Pflum, and Robert D Nelson
- Subjects
Male ,Time Factors ,Critical Care and Emergency Medicine ,Epidemiology ,Physiology ,Ambulances ,Transportation ,030204 cardiovascular system & hematology ,Chest pain ,Biochemistry ,Electrocardiography ,0302 clinical medicine ,Risk Factors ,Medicine and Health Sciences ,Myocardial infarction ,Prospective cohort study ,Multidisciplinary ,medicine.diagnostic_test ,biology ,Heart ,Middle Aged ,Troponin ,Body Fluids ,Bioassays and Physiological Analysis ,Blood ,Cardiovascular Diseases ,Cardiology ,Engineering and Technology ,Medicine ,Female ,Anatomy ,medicine.symptom ,Risk assessment ,Research Article ,Adult ,medicine.medical_specialty ,Point-of-Care Systems ,Science ,Pain ,Research and Analysis Methods ,Risk Assessment ,Sensitivity and Specificity ,03 medical and health sciences ,Signs and Symptoms ,Internal medicine ,medicine ,Humans ,Aged ,business.industry ,Electrophysiological Techniques ,Biology and Life Sciences ,Proteins ,030208 emergency & critical care medicine ,Emergency department ,medicine.disease ,Cytoskeletal Proteins ,Medical Risk Factors ,Cardiovascular Anatomy ,biology.protein ,Cardiac Electrophysiology ,Clinical Medicine ,business ,Biomarkers ,Mace - Abstract
The HEART Pathway is a validated risk stratification protocol for Emergency Department patients with chest pain that has yet to be tested in the prehospital setting. This study seeks to test the performance of a prehospital modified HEART Pathway (PMHP). A prospective cohort study of adults with chest pain without ST-segment elevation myocardial infarction was conducted at three EMS agencies between 12/2016-1/2018. To complete a PMHP assessment, paramedics drew blood, measured point-of-care (POC) troponin (i-STAT; Abbott Point of Care) and calculated a HEAR score. Patients were stratified into three groups: high-risk based on an elevated troponin, low-risk based on a HEAR score
- Published
- 2020
17. Acute Aortic Dissection: Is There Something Better than Physician Gestalt?
- Author
-
Lane M. Smith and Chadwick D. Miller
- Subjects
Aortic dissection ,medicine.medical_specialty ,business.industry ,MEDLINE ,030208 emergency & critical care medicine ,General Medicine ,030204 cardiovascular system & hematology ,medicine.disease ,Aortic Aneurysm ,Surgery ,Aortic Dissection ,03 medical and health sciences ,Aortic aneurysm ,0302 clinical medicine ,Aneurysm ,Case-Control Studies ,Emergency Medicine ,medicine ,Humans ,Gestalt psychology ,business - Published
- 2018
18. Response by Mahler et al to Letter Regarding Article, 'Safely Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge: HEART Pathway Accelerated Diagnostic Protocol'
- Author
-
Brian J. Wells, L. Douglas Case, Simon A. Mahler, Wendell M. Futrell, Jose-Franck Diaz-Garelli, Pamela W. Duncan, Kristin M. Lenoir, Gregory L. Burke, David M. Herrington, Brian Hiestand, and Chadwick D. Miller
- Subjects
Protocol (science) ,Patient discharge ,medicine.medical_specialty ,business.industry ,MEDLINE ,Emergency department ,Chest pain ,Physiology (medical) ,Emergency medicine ,medicine ,Acute chest pain ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Early discharge - Published
- 2019
19. ACES (Accelerated Chest Pain Evaluation With Stress Imaging) Protocols Eliminate Testing Disparities in Patients With Chest Pain
- Author
-
Sujethra Vasu, Chadwick D. Miller, Ronny A. Bell, L. Doug Case, W. Gregory Hundley, Jason P. Stopyra, and Simon A. Mahler
- Subjects
Male ,Acute coronary syndrome ,medicine.medical_specialty ,Chest Pain ,medicine.medical_treatment ,Stress testing ,030204 cardiovascular system & hematology ,Chest pain ,Risk Assessment ,Article ,law.invention ,Diagnosis, Differential ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Acute Coronary Syndrome ,Cardiac catheterization ,Aged ,Pain Measurement ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Emergency department ,Middle Aged ,medicine.disease ,Troponin ,Clinical trial ,Exercise Test ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Emergency Service, Hospital - Abstract
Background Patients from racial and ethnic minority groups presenting to the Emergency Department (ED) with chest pain experience lower odds of receiving stress testing compared with nonminorities. Studies have demonstrated that care pathways administered within the ED can reduce health disparities, but this has yet to be studied as a strategy to increase stress testing equity. Methods A secondary analysis from 3 randomized clinical trials involving ED patients with acute chest pain was performed to determine whether a care pathway, ACES (Accelerated Chest pain Evaluation with Stress imaging), reduces the racial disparity in index visit cardiac testing between African American (AA) and White patients. Three hundred thirty-four participants with symptoms and findings indicating intermediate to high risk for acute coronary syndrome were enrolled in 3 clinical trials. Major exclusions were ST-segment elevation, initial troponin elevation, and hemodynamic instability. Participants were randomly assigned to receive usual inpatient care, or ACES. The ACES care pathway includes placement in observation for serial cardiac markers, with an expectation for stress imaging. The primary outcome was index visit objective cardiac testing, compared among AA and White participants. Results AA participants represented 111/329 (34%) of the study population, 80/220 (36%) of the ACES group and 31/109 (28%) of the usual care group. In usual care, objective testing occurred less frequently among AA (22/31, 71%) than among White (69/78, 88%, P = 0.027) participants, primarily driven by cardiac catheterization (3% vs. 24%; P = 0.012). In ACES, testing rates did not differ by race [AA 78/80 (98%) vs. White 138/140 (99%); P = 0.623]. At 90 days, death, MI, and revascularization did not differ in either group between AA and White participants. Conclusions A care pathway with the expectation for stress imaging eliminates the racial disparity among AA and White participants with chest pain in the acquisition of index-visit cardiovascular testing.
- Published
- 2019
20. Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications
- Author
-
Chadwick D. Miller, Anna Marie Chang, Erin Greco, Bradley S. Snyder, Harjit Singh, Constantine Gatsonis, Katie J. O’Conor, Harold Litt, and Judd E. Hollander
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,Aspirin ,business.industry ,Emergency department ,030204 cardiovascular system & hematology ,medicine.disease ,Chest pain ,Coronary artery disease ,03 medical and health sciences ,Stenosis ,0302 clinical medicine ,Informed consent ,Physiology (medical) ,Multicenter trial ,Internal medicine ,medicine ,Cardiology ,030212 general & internal medicine ,Radiology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
Coronary computed tomography angiography (CCTA) has been shown to be highly sensitive for coronary artery disease and acute coronary syndrome.1,2 Few studies have evaluated changes in medical management after CCTA.3,4 Prior studies suggest increases in medical management in the cardiology setting, but none has directly compared CCTA to standard emergency department (ED) care. We sought to determine the difference in initiation of aspirin or statins depending on whether patients were evaluated with CCTA or standard care for acute chest pain. This is a prespecified analysis of a randomized controlled multicenter trial comparing a CCTA-based strategy with traditional rule-out approaches for low- to intermediate-risk patients presenting to the ED with chest pain and possible acute coronary syndrome (ClinicalTrials.gov number: NCT00933400). The full study protocol has been published elsewhere.1 Briefly, patients ≥30 years of age with possible acute coronary syndrome were enrolled and randomized in EDs or observation units at 5 sites. This study was approved by the institutional review boards at participating sites, and all patients provided written informed consent. The degree of maximal stenosis was defined as the maximal stenosis reported from the CCTA scan and was categorized as follows: none, no stenosis; mild, 1% to 49%; moderate, 50% to …
- Published
- 2017
21. Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure
- Author
-
Carolyn S. Calfee, Kathleen Tiffany Lee, David T. Huang, Russell R. Miller, Donald M. Yealy, Peter C. Hou, Chadwick D. Miller, David A. Schoenfeld, Roy G. Brower, Robert C. Hyzy, Jay S. Steingrub, Ary Serpa-Neto, Samuel M. Brown, Mark Tidswell, Michael J. Lanspa, Kusum S. Mathews, Michael A. Matthay, Gregory W. Hendey, Terry P. Clemmer, Nida Qadir, Michelle N. Gong, B. Taylor Thompson, Theodore J. Iwashyna, Colin K. Grissom, and Catherine L. Hough
- Subjects
Male ,medicine.medical_treatment ,0302 clinical medicine ,Medicine ,Hospital Mortality ,Prospective Studies ,Lung ,Acute Respiratory Distress Syndrome ,The National Heart ,low-tidal volume ventilation ,Clinical Trials as Topic ,Respiration ,Incidence ,Lung protective ventilation ,Middle Aged ,Survival Rate ,Intensive Care Units ,Treatment Outcome ,Low tidal volume ,Anesthesia ,Artificial ,Acute Disease ,Respiratory ,Breathing ,lung-protective ventilation ,Female ,Patient Safety ,Respiratory Insufficiency ,Pulmonary and Respiratory Medicine ,and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network ,Clinical Trials and Supportive Activities ,Acute respiratory distress ,low-stretch ventilation ,mechanical ventilation ,03 medical and health sciences ,Rare Diseases ,Clinical Research ,Tidal Volume ,Humans ,Acute respiratory failure ,Mechanical ventilation ,business.industry ,030208 emergency & critical care medicine ,Respiration, Artificial ,United States ,low–tidal volume ventilation ,Good Health and Well Being ,030228 respiratory system ,Respiratory failure ,Feasibility Studies ,business ,Follow-Up Studies - Abstract
RationaleLow-tidal volume ventilation (LTVV; 6 ml/kg) benefits patients with acute respiratory distress syndrome and may aid those with other causes of respiratory failure. Current early ventilation practices are poorly defined.ObjectivesWe observed patients with acute respiratory failure to assess the feasibility of a pragmatic trial of LTVV and to guide experimental design.MethodsWe prospectively enrolled consecutive patients with acute respiratory failure admitted to intensive care units expected to participate in the proposed trial. We collected clinical data as well as information on initial and daily ventilator settings and inpatient mortality. We estimated the benefit of LTVV using predictive linear and nonlinear models. We simulated models to estimate power and feasibility of a cluster-randomized trial of LTVV versus usual care in acute respiratory failure.ResultsWe included 2,484 newly mechanically ventilated patients (31% with acute respiratory distress syndrome) from 49 hospitals. Hospital mortality was 28%. Mean initial tidal volume was 7.1 ml/kg predicted body weight (95% confidence interval, 7.1-7.2), with 78% of patients receiving tidal volumes less than or equal to 8 ml/kg. Our models estimated a mortality benefit of 0-2% from LTVV compared with usual care. Simulation of a stepped-wedged cluster-randomized trial suggested that enrollment of 106,361 patients would be necessary to achieve greater than 90% power.ConclusionsUse of initial tidal volumes less than 8 ml/kg predicted body weight was common at hospitals participating in the National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Network. After considering the size and budgetary requirement for a cluster-randomized trial of LTVV versus usual care in acute respiratory failure, the PETAL Network deemed the proposed trial infeasible. A rapid observational study and simulations to model anticipated power may help better design trials.
- Published
- 2018
22. 272EMF Using Monocyte Chemoattractant Protein-1 to Predict Adverse Cardiovascular Events among Emergency Department Chest Pain Patients
- Author
-
Simon A. Mahler, Robert H. Christenson, Anna C. Snavely, Brandon Allen, Jason P. Stopyra, Brian Hiestand, Chadwick D. Miller, David M. Herrington, and Nicklaus P. Ashburn
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,Emergency Medicine ,medicine ,Emergency department ,medicine.symptom ,Chest pain ,business ,Monocyte chemoattractant protein - Published
- 2020
23. 271EMF Advancing Emergency Department Chest Pain Risk Stratification With Monocyte Chemoattractant Protein-1 and High-Sensitivity Troponin
- Author
-
Brian Hiestand, Robert H. Christenson, Anna C. Snavely, Jason P. Stopyra, Chadwick D. Miller, David M. Herrington, Brandon Allen, Simon A. Mahler, and Nicklaus P. Ashburn
- Subjects
medicine.medical_specialty ,business.industry ,High sensitivity troponin ,Internal medicine ,Risk stratification ,Emergency Medicine ,Cardiology ,medicine ,Emergency department ,medicine.symptom ,Chest pain ,business ,Monocyte chemoattractant protein - Published
- 2020
24. Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation
- Author
-
William Arnold, John T. Nagurney, Chadwick D. Miller, Elizabeth Lee-Lewandrowski, Jon W. Schrock, Robert H. Birkhahn, Judd E. Hollander, Francis L. Counselman, Deborah B. Diercks, Abhinav Chandra, Basmah Safdar, Joshua M. Kosowsky, Mary Ann Peberdy, Richard Nowak, Adam J. Singer, W. Frank Peacock, and James Neuenschwander
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,Point-of-Care Systems ,Clinical Biochemistry ,Population ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Diagnostic accuracy ,Sensitivity and Specificity ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Troponin I ,medicine ,Humans ,030212 general & internal medicine ,Myocardial infarction ,Prospective Studies ,Acute Coronary Syndrome ,Prospective cohort study ,Intensive care medicine ,education ,education.field_of_study ,Clinical Chemistry ,biology ,business.industry ,Biochemistry (medical) ,General Medicine ,Emergency department ,medicine.disease ,Troponin ,Triage ,Point-of-care ,biology.protein ,Emergency medicine ,Original Article ,Reagent Kits, Diagnostic ,business ,Emergency Service, Hospital ,Laboratories ,Biomarkers - Abstract
Background We aimed to compare the diagnostic accuracy of the Alere Triage Cardio3 Tropinin I (TnI) assay (Alere, Inc., USA) and the PathFast cTnI-II (Mitsubishi Chemical Medience Corporation, Japan) against the central laboratory assay Singulex Erenna TnI assay (Singulex, USA). Methods Using the Markers in the Diagnosis of Acute Coronary Syndromes (MIDAS) study population, we evaluated the ability of three different assays to identify patients with acute myocardial infarction (AMI). The MIDAS dataset, described elsewhere, is a prospective multicenter dataset of emergency department (ED) patients with suspected acute coronary syndrome (ACS) and a planned objective myocardial perfusion evaluation. Myocardial infarction (MI) was diagnosed by central adjudication. Results The C-statistic with 95% confidence intervals (CI) for diagnosing MI by using a common population (n=241) was 0.95 (0.91-0.99), 0.95 (0.91-0.99), and 0.93 (0.89-0.97) for the Triage, Singulex, and PathFast assays, respectively. Of samples with detectable troponin, the absolute values had high Pearson (R(P)) and Spearman (R(S)) correlations and were R(P)=0.94 and R(S)=0.94 for Triage vs Singulex, R(P)=0.93 and R(S)=0.85 for Triage vs PathFast, and R(P)=0.89 and R(S)=0.73 for PathFast vs Singulex. Conclusions In a single comparative population of ED patients with suspected ACS, the Triage Cardio3 TnI, PathFast, and Singulex TnI assays provided similar diagnostic performance for MI.
- Published
- 2016
25. Traumatic hand degloving injury by conveyor belt
- Author
-
Chase Glenn, Nicklaus P. Ashburn, and Chadwick D. Miller
- Subjects
Degloving ,medicine.medical_specialty ,business.industry ,Emergency Medicine ,medicine ,Conveyor belt ,medicine.disease ,business ,Surgery - Published
- 2020
26. NATIVE T1 MAPPING USING CMR ADENOSINE STRESS PROTOCOL IS ASSOCIATED WITH TROPONIN LEVELS IN PATIENTS WITH CHEST PAIN AND DETECTABLE TROPONINS: SUB-ANALYSIS OF THE CMR-IMPACT TRIAL
- Author
-
Michael E. Hall, William W. Hundley, Chadwick D. Miller, Jennifer H. Jordan, Carolyn J. Park, and Subha V. Raman
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Adenosine stress ,Chest pain ,Troponin ,Internal medicine ,medicine ,Cardiology ,biology.protein ,In patient ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Published
- 2020
27. The <scp>HEART</scp> Pathway Randomized Controlled Trial One‐year Outcomes
- Author
-
Brian Hiestand, Jason P. Stopyra, Simon A. Mahler, Chadwick D. Miller, Kim Askew, Gregory B. Russell, David M. Cline, James W. Hoekstra, Gregory L. Burke, David M. Herrington, Bret A. Nicks, Robert F. Riley, Cedric Lefebvre, and Stephanie B. Elliott
- Subjects
Adult ,Male ,Chest Pain ,medicine.medical_specialty ,Randomization ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Coronary Angiography ,Chest pain ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Outcome Assessment, Health Care ,medicine ,Humans ,Myocardial infarction ,Aged ,biology ,business.industry ,030208 emergency & critical care medicine ,General Medicine ,Emergency department ,Middle Aged ,medicine.disease ,Troponin ,Critical Pathways ,Emergency Medicine ,biology.protein ,Female ,Myocardial infarction diagnosis ,medicine.symptom ,Emergency Service, Hospital ,business ,Mace - Abstract
Objective The objective was to determine the impact of the HEART Pathway on health care utilization and safety outcomes at 1 year in patients with acute chest pain. Methods Adult emergency department (ED) patients with chest pain (N = 282) were randomized to the HEART Pathway or usual care. In the HEART Pathway arm, ED providers used the HEART score and troponin measures (0 and 3 hours) to risk stratify patients. Usual care was based on American College of Cardiology/American Heart Association guidelines. Major adverse cardiac events (MACE-cardiac death, myocardial infarction [MI], or coronary revascularization), objective testing (stress testing or coronary angiography), and cardiac hospitalizations and ED visits were assessed at 1 year. Randomization arm outcomes were compared using Fisher's exact tests. Results A total of 282 patients were enrolled, with 141 randomized to each arm. MACE at 1 year occurred in 10.6% (30/282): 9.9% in the HEART Pathway arm (14/141; 10 MIs, four revascularizations without MI) versus 11.3% in usual care (16/141; one cardiac death, 13 MIs, two revascularizations without MI; p = 0.85). Among low-risk HEART Pathway patients, 0% (0/66) had MACE, with a negative predictive value (NPV) of 100% (95% confidence interval = 93%-100%). Objective testing through 1 year occurred in 63.1% (89/141) of HEART Pathway patients compared to 71.6% (101/141) in usual care (p = 0.16). Nonindex cardiac-related hospitalizations and ED visits occurred in 14.9% (21/141) and 21.3% (30/141) of patients in the HEART Pathway versus 10.6% (15/141) and 16.3% (23/141) in usual care (p = 0.37, p = 0.36). Conclusions The HEART Pathway had a 100% NPV for 1-year safety outcomes (MACE) without increasing downstream hospitalizations or ED visits. Reduction in 1-year objective testing was not significant.
- Published
- 2018
28. Monocyte Chemoattractant Protein-1 as a Predictor of Coronary Atherosclerosis in Patients Receiving Coronary Angiography
- Author
-
Thomas C. Register, Ralph B. D'Agostino, Chadwick D. Miller, Simon A. Mahler, Jason P. Stopyra, and Robert F. Riley
- Subjects
Adult ,Male ,medicine.medical_specialty ,Acute coronary syndrome ,Cardiac Catheterization ,Computed Tomography Angiography ,medicine.medical_treatment ,Myocardial Infarction ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Chest pain ,Coronary Angiography ,Article ,Coronary artery disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,mental disorders ,medicine ,Myocardial Revascularization ,Odds Ratio ,Humans ,Myocardial infarction ,cardiovascular diseases ,Coronary atherosclerosis ,Chemokine CCL2 ,Cardiac catheterization ,Computed tomography angiography ,Aged ,medicine.diagnostic_test ,business.industry ,nutritional and metabolic diseases ,030208 emergency & critical care medicine ,Odds ratio ,Middle Aged ,medicine.disease ,Logistic Models ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Animal studies suggest that monocyte chemoattractant protein-1 (MCP-1) is a promising biomarker for coronary artery atherosclerosis (CAA), but human studies have been inconclusive. Objective To determine potential relationships between plasma MCP-1 and CAA in patients with acute chest pain. Methods A secondary analysis of 150 patients enrolled in emergency department chest pain risk stratification clinical investigations was conducted. Participants with stored blood and known coronary phenotypes (determined by coronary angiography) were selected using stratified randomization such that 50 patients were included into 3 groups: (1) no angiographic evidence of CAA, (2) nonobstructive CAA, and (3) obstructive CAA (stenosis ≥ 70%). Plasma MCP-1 levels were determined by enzyme-linked immunosorbent assay. The association between MCP-1 and obstructive CAA or any CAA was modeled using logistic regression. Variables in the unreduced model included age, sex, race, prior diagnosis of CAA or acute coronary syndrome, hyperlipidemia, hypertension, diabetes, smoking, and cardiac troponin I measurement. Results Among the 150 participants, 65.3% (98/150) had invasive coronary angiography and 34.7% (52/150) had coronary computed tomographic angiography. Myocardial infarction occurred in 27.3% (41/150) and coronary revascularization occurred in 26% (39/150) of the participants. Each 10 pg/mL increase in MCP-1 measurement was associated with an odds ratio of 1.12 (95% confidence interval, 1.06-1.19) for obstructive CAA. MCP-1 remained a significant predictor of obstructive CAA and any CAA after adjustment for age, sex, race, traditional cardiac risk factors, and cardiac troponin I. Conclusions MCP-1 is independently associated with CAA among emergency department patients with chest pain.
- Published
- 2018
29. Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial
- Author
-
Kathleen D. Liu, Adit A. Ginde, Donald M. Yealy, Nathan I. Shapiro, Ivor S. Douglas, Colin K. Grissom, Todd W. Rice, Daniel Talmor, Rinaldo Bellomo, Stephen P J Macdonald, David R. Janz, Matthew W. Semler, Samuel M. Brown, Pauline K. Park, Bennett P. deBoisblanc, Chadwick D. Miller, Jay S. Steingrub, Matthew C. Exline, Nhlbi Prevention, Wesley H. Self, Alan E. Jones, and Lora A. Reineck
- Subjects
Resuscitation ,Drug Administration Schedule ,Article ,law.invention ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Edema ,medicine ,Humans ,Vasoconstrictor Agents ,030212 general & internal medicine ,Infusions, Intravenous ,Randomized Controlled Trials as Topic ,business.industry ,Septic shock ,Organ dysfunction ,030208 emergency & critical care medicine ,medicine.disease ,Shock, Septic ,Blood pressure ,Research Design ,Shock (circulatory) ,Anesthesia ,Emergency Medicine ,Fluid Therapy ,medicine.symptom ,business - Abstract
Prompt intravenous fluid therapy is a fundamental treatment for patients with septic shock. However, the optimal approach for administering intravenous fluid in septic shock resuscitation is unknown. Two competing strategies are emerging—a liberal fluids approach consisting of a larger volume of initial fluid [50 – 75 ml/kg (4–6 liters in an 80 kg adult) over the first 6 hours] and later use of vasopressors, versus a restrictive fluids approach consisting of a smaller volume of initial fluid [≤30 ml/kg (≤2–3 liters)] with earlier reliance on vasopressor infusions to maintain blood pressure and perfusion. Early fluid therapy may enhance or maintain tissue perfusion by increasing venous return and cardiac output. However, fluid administration may also have deleterious effects by causing edema within vital organs, leading to organ dysfunction and impairment of oxygen delivery. Conversely, a restrictive fluids approach primarily relies on vasopressors to reverse hypotension and maintain perfusion while limiting the administration of fluid. Both strategies have some evidence to support their use, but lack robust data to confirm the benefit of one strategy over the other, creating clinical and scientific equipoise. As part of the National Heart, Lung and Blood Institute (NHLBI) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network, we designed a randomized clinical trial to compare the liberal and restrictive fluids strategies—the Crystalloid Liberal Or Vasopressor Early Resuscitation in Sepsis (CLOVERS) trial. The purpose of this manuscript is to review the current literature on approaches to early fluid resuscitation in adults with septic shock and outline the rationale for the upcoming trial.
- Published
- 2018
30. Usefulness of Serial 12-Lead Electrocardiograms in Predicting 30-Day Outcomes in Patients With Undifferentiated Chest Pain (the ASAP CATH Study)
- Author
-
David M. Herrington, Chadwick D. Miller, Elsayed Z. Soliman, Brian Hiestand, Gregory B. Russell, Robert F. Riley, and Simon A. Mahler
- Subjects
Adult ,Male ,medicine.medical_specialty ,Acute coronary syndrome ,Chest Pain ,Time Factors ,030204 cardiovascular system & hematology ,Chest pain ,Single Center ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,030212 general & internal medicine ,Prospective Studies ,Acute Coronary Syndrome ,Prospective cohort study ,Aged ,Ohio ,biology ,business.industry ,ST elevation ,Incidence ,Emergency department ,Middle Aged ,medicine.disease ,Prognosis ,Troponin ,Predictive value of tests ,biology.protein ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Emergency Service, Hospital ,Follow-Up Studies - Abstract
An initial electrocardiogram (ECG) and serial troponin measurements are both independently and incrementally predictive of acute coronary syndrome in patients presenting with undifferentiated chest pain in the Emergency Department (ED). However, it is unclear if serial (ECGs) add significant to the contemporary diagnostic evaluation of this patient group. The ASAP CATH study was a single center, prospective study that enrolled patients presenting to an ED with undifferentiated chest pain. In addition to standard clinical evaluation, serial ECGs were performed at 90-minute intervals to evaluate whether serial changes suggestive of ischemia developed (Q waves, ST elevation or depression, or T-wave inversion). Total 365 subjects were enrolled from March 2014 to May 2015. Serial ECG changes developed in 6.6% (n = 24 of 365), the most common being the development of T-wave inversion (66.7%, n = 16 of 24). The sensitivity and positive predictive value of serial ECG changes were poor (30%), with a less areas under the curve (0.55) compared with serial troponins alone (0.83). The addition of serial ECG changes to Thrombolysis In Myocardial Infarction risk scoring showed a decrease in the net reclassification index for major adverse cardiovascular events (-0.04, p0.1) and was not significant for the prediction of major adverse cardiovascular events and/or acute coronary syndrome in 30 days (-0.003, p = 0.94). In conclusion, routine serial ECG evaluation for patients presenting with undifferentiated chest pain in the ED may not significantly improved diagnostic prognosis beyond current standard evaluation modalities.
- Published
- 2018
31. Prehospital Modified HEART Score Predictive of 30-Day Adverse Cardiac Events
- Author
-
James E. Winslow, Gregory B. Russell, Julia V Prokesova, Simon A. Mahler, Christopher A. Davis, Robert D Nelson, Roy L. Alson, Tyson J Higgins, Chadwick D. Miller, Jason P. Stopyra, and William S Harper
- Subjects
Adult ,Male ,medicine.medical_specialty ,Acute coronary syndrome ,Chest Pain ,Emergency Medical Services ,Time Factors ,Clinical Decision-Making ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Emergency Nursing ,Chest pain ,Risk Assessment ,Severity of Illness Index ,Cohort Studies ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Troponin T ,Predictive Value of Tests ,Internal medicine ,medicine ,Emergency medical services ,Humans ,Myocardial infarction ,Acute Coronary Syndrome ,Aged ,Retrospective Studies ,biology ,business.industry ,030208 emergency & critical care medicine ,Retrospective cohort study ,Emergency department ,Middle Aged ,medicine.disease ,Troponin ,United States ,Survival Rate ,Emergency Medicine ,Cardiology ,biology.protein ,Female ,medicine.symptom ,business ,Emergency Service, Hospital ,Mace ,Follow-Up Studies - Abstract
IntroductionThe History, Electrocardiogram (ECG), Age, Risk Factors, and Troponin (HEART) score is a decision aid designed to risk stratify emergency department (ED) patients with acute chest pain. It has been validated for ED use, but it has yet to be evaluated in a prehospital setting.HypothesisA prehospital modified HEART score can predict major adverse cardiac events (MACE) among undifferentiated chest pain patients transported to the ED.MethodsA retrospective cohort study of patients with chest pain transported by two county-based Emergency Medical Service (EMS) agencies to a tertiary care center was conducted. Adults without ST-elevation myocardial infarction (STEMI) were included. Inter-facility transfers and those without a prehospital 12-lead ECG or an ED troponin measurement were excluded. Modified HEART scores were calculated by study investigators using a standardized data collection tool for each patient. All MACE (death, myocardial infarction [MI], or coronary revascularization) were determined by record review at 30 days. The sensitivity and negative predictive values (NPVs) for MACE at 30 days were calculated.ResultsOver the study period, 794 patients met inclusion criteria. A MACE at 30 days was present in 10.7% (85/794) of patients with 12 deaths (1.5%), 66 MIs (8.3%), and 12 coronary revascularizations without MI (1.5%). The modified HEART score identified 33.2% (264/794) of patients as low risk. Among low-risk patients, 1.9% (5/264) had MACE (two MIs and three revascularizations without MI). The sensitivity and NPV for 30-day MACE was 94.1% (95% CI, 86.8-98.1) and 98.1% (95% CI, 95.6-99.4), respectively.ConclusionsPrehospital modified HEART scores have a high NPV for MACE at 30 days. A study in which prehospital providers prospectively apply this decision aid is warranted.StopyraJP, HarperWS, HigginsTJ, ProkesovaJV, WinslowJE, NelsonRD, AlsonRL, DavisCA, RussellGB, MillerCD, MahlerSA. Prehospital modified HEART score predictive of 30-day adverse cardiac events. Prehosp Disaster Med. 2018;33(1):58–62.
- Published
- 2018
32. Injury patterns associated with hypotension in pediatric trauma patients
- Author
-
Debra I. Diz, Chadwick D. Miller, Janet A. Tooze, Alison R. Gardner, and John K. Petty
- Subjects
Male ,Adolescent ,Poison control ,Hemorrhage ,Critical Care and Intensive Care Medicine ,Risk Assessment ,Injury Severity Score ,Trauma Centers ,Injury prevention ,medicine ,Craniocerebral Trauma ,Humans ,Glasgow Coma Scale ,Registries ,Child ,Spinal Cord Injuries ,Retrospective Studies ,business.industry ,Incidence ,Head injury ,Infant, Newborn ,Infant ,Retrospective cohort study ,Emergency department ,medicine.disease ,United States ,Child, Preschool ,Anesthesia ,Female ,Surgery ,Hypotension ,business ,Pediatric trauma - Abstract
BACKGROUND: Hypotension after trauma is most commonly assumed to be hemorrhagic, or hypovolemic, in origin. However, hypotension may occur in pediatric patients with isolated head injury, challenging accepted tenets of trauma care. We sought to quantify the contribution of head injury to the development of hypotension after pediatric trauma. METHODS: This is a retrospective cohort analysis using the National Trauma Data Bank registry 2009. Children aged 0 to 15 years were classified by injury pattern sustained during trauma using discharge diagnosis International Classification of Diseases, Ninth Revision, codes into isolated head, hemorrhagic, spinal cord, or other injury type. The primary outcome was hypotension for age at arrival to the emergency department. Risk of hypotension was estimated and compared by injury pattern using absolute and relative risks (RRs) stratified by age group (0-4 years, 5-11 years, 12-15 years). RESULTS: Rates of hypotension ranged from 1.8% to 2.3% by age, with the highest incidence in the 12- to 15-year group. The RR of hypotension from isolated head injury (RR, 2.5; 95% confidence interval, 2.0-3.2 vs. other) was not significantly different from the RR for hemorrhagic injury (RR, 2.7; 95% confidence interval, 2.1-3.5 vs. other) in the 0- to 4-year-old group. For the older age groups, the RR of hypotension from isolated head injury was significantly lower than from hemorrhagic injury. CONCLUSION: Hypotension occurs after isolated head injury in children, and the risk of hypotension is as great as hemorrhagic injuries in children aged 0 to 4 years. This finding should now lead us to confirm whether a cause-effect relationship exists and, if so, isolate the responsible mechanism. In turn, this could reveal an opportunity to tailor treatments to address the underlying mechanism for hypotension in these children. LEVEL OF EVIDENCE: Prognostic and epidemiologic study, level III. Language: en
- Published
- 2015
33. Performance of the 2-hour Accelerated Diagnostic Protocol Within the American College of Radiology Imaging Network PA 4005 Cohort
- Author
-
Bradley S. Snyder, Harold Litt, Judd E. Hollander, Simon A. Mahler, Chadwick D. Miller, and Constantine Gatsonis
- Subjects
Male ,Chest Pain ,Acute coronary syndrome ,medicine.medical_specialty ,Stress testing ,Myocardial Infarction ,Chest pain ,Risk Assessment ,Severity of Illness Index ,Article ,Electrocardiography ,Clinical Protocols ,medicine ,Humans ,Prospective Studies ,Myocardial infarction ,Acute Coronary Syndrome ,Intensive care medicine ,Prospective cohort study ,Aged ,business.industry ,Reproducibility of Results ,General Medicine ,Middle Aged ,medicine.disease ,Patient Discharge ,United States ,Emergency medicine ,Cohort ,Emergency Medicine ,Female ,medicine.symptom ,Emergency Service, Hospital ,business ,Biomarkers ,Mace ,TIMI - Abstract
Approximately 8 to 10 million patients complaining of chest pain present to emergency departments (EDs) annually in the United States.1 In an attempt to avoid missing the diagnosis of acute coronary syndrome (ACS), emergency physicians use liberal testing strategies in patients with acute chest pain. This results in more than 50% of ED patients with acute chest pain receiving comprehensive cardiac evaluations (serial cardiac biomarkers and stress testing or angiography) at an estimated cost of $10 to $13 billion annually,2–6 yet fewer than 10% of these patients are ultimately diagnosed with ACS.6–10 Current care patterns for patients with acute chest pain fail to focus health system resources on patients likely to benefit. Among low-risk patients who have ACS rates as low as 2%, stress testing and cardiac imaging is associated with a substantial number of false-positive and nondiagnostic tests, which leads to additional unnecessary and often invasive procedures.11 Consensus among health system leaders, clinicians, and educators is building regarding the need to more efficiently evaluate patients with acute chest pain.12 The 2-hour accelerated diagnostic protocol (ADAPT),13,14 which combines 0- and 2-hour cardiac troponin (cTn) tests, electrocardiograms (ECGs), and an adapted Thombolysis in Myocardial Infarction (TIMI) score, is a recently developed decision rule designed to identify ED patients safe for early discharge. Previous studies in the Asia-Pacific region have demonstrated that ADAPT can classify 20% of patients with acute chest pain for early discharge while simultaneously achieving high sensitivity (97.9% to 99.7%) for major adverse cardiac events (MACE) at 30 days.13,15 Based on these studies, many believe that ADAPT has the potential to more efficiently focus inpatient resources and objective cardiac testing (stress testing or angiography) on patients likely to benefit. However, the performance of ADAPT within a cohort of US ED patients has yet to be examined. We designed a secondary data analysis of the American College of Radiology Imaging Network (ACRIN) PA 4005 cohort to determine the validity of ADAPT in a group of U.S. ED patients with suspected ACS. Specifically we sought to determine if ADAPT can classify 20% or more patients with acute chest pain as safe for early discharge while maintaining high sensitivity and negative predictive value (NPV) for MACE. While the precise value of an acceptable sensitivity and NPV for MACE is a matter of considerable debate, many believe that a successful chest pain risk stratification strategy must achieve >99% NPV (corresponding with a < 1% missed MACE rate among patients with a low-risk assessment) and approach a 99% sensitivity.16
- Published
- 2015
34. Impact of Coronary Calcification on Clinical Management in Patients With Acute Chest Pain
- Author
-
Daniel O. Bittner, Fabian Bamberg, John T. Nagurney, Sumbal Janjua, Harold Litt, Pamela K. Woodard, Maros Ferencik, Daniel Addison, Travis R. Hallett, Udo Hoffmann, Harjit Singh, Anna Marie Chang, Judd E. Hollander, Thomas Mayrhofer, James E. Udelson, Michael T. Lu, Chadwick D. Miller, and Quynh A. Truong
- Subjects
Male ,Chest Pain ,medicine.medical_specialty ,Acute coronary syndrome ,030204 cardiovascular system & hematology ,Coronary Angiography ,Chest pain ,Risk Assessment ,Article ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Artery calcification ,Risk Factors ,Internal medicine ,medicine ,Acute chest pain ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,cardiovascular diseases ,030212 general & internal medicine ,Acute Coronary Syndrome ,Vascular Calcification ,business.industry ,Coronary computed tomography angiography ,Calcinosis ,Reproducibility of Results ,Middle Aged ,medicine.disease ,Coronary artery calcification ,Acute Disease ,Cardiology ,Diagnostic assessment ,Calcium ,Female ,Radiology ,medicine.symptom ,Emergency Service, Hospital ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background— Coronary artery calcification (CAC) may impair diagnostic assessment of coronary computed tomography angiography (CTA). We determined whether CAC affects efficiency of coronary CTA in patients with suspected acute coronary syndrome (ACS). Methods and Results— This is a pooled analysis of ACRIN-PA (American College of Radiology Imaging Network–Pennsylvania) 4005 and the ROMICAT-II trial (Rule Out Myocardial Infarction/Ischemia Using Computer Assisted Tomography) comparing an initial coronary CTA strategy to standard of care in acute chest pain patients. In the CTA arms, we investigated appropriateness of downstream testing, cost, and diagnostic yield to identify patients with obstructive coronary artery disease on subsequent invasive coronary angiography across CAC score strata (Agatston score: 0, >0–10, >10–100, >100–400, >400). Out of 1234 patients (mean age 51±8.8 years), 80 (6.5%) had obstructive coronary artery disease (≥70% stenosis) and 68 (5.5%) had ACS. Prevalence of obstructive coronary artery disease (1%–64%), ACS (1%–44%), downstream testing (4%–72%), and total (2337–8484 US$) and diagnostic cost (2310–6678 US$) increased across CAC strata ( P 400, cost to diagnose one ACS was lowest in this group (19 283 US$ versus 464 399 US$) as compared with patients without CAC. The diagnostic yield of invasive coronary angiography was highest in patients with CAC>400 (87% versus 38%). Conclusions— Downstream testing, total, and diagnostic cost increased with increasing CAC, but were found to be appropriate because obstructive coronary artery disease and ACS were more prevalent in patients with high CAC. In patients with acute chest pain undergoing coronary CTA, cost-efficient testing and excellent diagnostic yield can be achieved even with high CAC burden. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifiers: NCT01084239 and NCT00933400.
- Published
- 2017
35. Validation of the No Objective Testing Rule and Comparison to the HEART Pathway
- Author
-
Kim Askew, James W. Hoekstra, David M. Cline, Gregory B. Russell, Chadwick D. Miller, Jason P. Stopyra, Brian Hiestand, Bret A. Nicks, Robert F. Riley, Simon A. Mahler, and Cedric Lefebvre
- Subjects
Adult ,medicine.medical_specialty ,Acute coronary syndrome ,Chest Pain ,Myocardial Infarction ,030204 cardiovascular system & hematology ,Chest pain ,Sensitivity and Specificity ,Article ,law.invention ,Decision Support Techniques ,Coronary artery disease ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Risk Factors ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,Acute Coronary Syndrome ,business.industry ,030208 emergency & critical care medicine ,General Medicine ,medicine.disease ,Surgery ,Cohort ,Emergency Medicine ,medicine.symptom ,business ,Emergency Service, Hospital ,Mace ,Cohort study - Abstract
Background The no objective testing rule (NOTR) is a decision aid designed to safely identify emergency department (ED) patients with chest pain who do not require objective testing for coronary artery disease. Objectives The objective was to validate the NOTR in a cohort of U.S. ED patients with acute chest pain and compare its performance to the HEART Pathway. Methods A secondary analysis of 282 participants enrolled in the HEART Pathway randomized controlled trial was conducted. Each patient was classified as low risk or at risk by the NOTR. Sensitivity for major adverse cardiac events (MACE) at 30 days was calculated in the entire study population. NOTR and HEART Pathways were compared among patients randomized to the HEART Pathway in the parent trial using McNemar's test and the net reclassification improvement (NRI). Results Major adverse cardiac events occurred in 22/282 (7.8%) participants, including no deaths, 16/282 (5.6%) with myocardial infarction (MI), and 6/282 (2.1%) with coronary revascularization without MI. NOTR was 100% (95% confidence interval [CI] = 84.6%–100%) sensitive for MACE and identified 78/282 patients (27.7%, 95% = CI 22.5–33.3%) as low risk. In the HEART Pathway arm (n = 141), both NOTR and HEART Pathway identified all patients with MACE as at risk. Compared to NOTR, the HEART Pathway was able to correctly reclassify 27 patients without MACE as low risk, yielding a NRI of 20.8% (95% CI = 11.3%–30.2%). Conclusions Within a U.S. cohort of ED patients with chest pain, the NOTR and HEART Pathway were 100% sensitive for MACE at 30 days. However, the HEART Pathway identified more patients suitable for early discharge than the NOTR.
- Published
- 2016
36. The Association between Self-reported Exercise Intensity and Acute Coronary Syndrome in Emergency Department Chest Pain Patients
- Author
-
Adam J. Singer, Deborah B. Diercks, Robert H. Birkhahn, Richard Nowack, Judd E. Hollander, Nathan I. Shapiro, John T. Nagurney, Ted Glynn, Basmah Safdar, Elizabeth Lee Lewandrowski, Chadwick D. Miller, Henry C. Thode, and W. Frank Peacock
- Subjects
Male ,Chest Pain ,medicine.medical_specialty ,Acute coronary syndrome ,Chest pain ,Coronary artery disease ,Risk Factors ,Interquartile range ,Internal medicine ,Odds Ratio ,medicine ,Humans ,Prospective Studies ,Acute Coronary Syndrome ,Prospective cohort study ,Exercise ,Aged ,business.industry ,Emergency department ,Odds ratio ,Middle Aged ,medicine.disease ,Physical Fitness ,Emergency Medicine ,Exercise intensity ,Cardiology ,Female ,medicine.symptom ,Emergency Service, Hospital ,business - Abstract
Background Regular exercise is thought to be protective against coronary artery disease. As a result, some physicians believe that the likelihood of acute coronary syndrome (ACS) in patients with acute chest pain is reduced in those who exercise regularly. We studied the association between self-reported frequency of exercising and the likelihood of ACS in patients presenting to the Emergency Department (ED) with chest pain. Methods A multi-center prospective, descriptive, cohort study design was used in ED patients to determine whether the risk of ACS was reduced in patients who self-reported regular exercise. Results There were 1093 patients enrolled. Median (interquartile range) age was 57 (48–67) years; 506 (45.7%) were female. ACS was diagnosed in 248 (22.7%) patients. Patients who did not exercise at least monthly were more likely to be diagnosed with ACS than those who did (129/466 [27.7%] vs. 119/627 [19.0%]; odds ratio 1.63, 95% CI 1.23–2.17). After adjusting for age, gender, body mass index, smoking, and prior history, limited exercise was still associated with ACS (adjusted odds ratio 1.52, 95% CI 1.10–2.10). There was no apparent association between frequency and intensity of exercise and risk of ACS. Conclusion Although self-reported frequency of exercise was significantly associated with a decrease in ACS in ED patients with chest pain, it should not be used to exclude ACS in symptomatic ED patients.
- Published
- 2013
37. Diagnostic Imaging to Exclude Acute Coronary Syndrome
- Author
-
Chadwick D. Miller and Simon A. Mahler
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,Modalities ,medicine.diagnostic_test ,business.industry ,Medical malpractice ,General Medicine ,Emergency department ,Chest pain ,medicine.disease ,Cardiac magnetic resonance imaging ,Medical imaging ,medicine ,Stress Echocardiography ,Radiology ,medicine.symptom ,Intensive care medicine ,business - Abstract
On virtually every shift, Emergency Department providers care for patients with chest pain. With each encounter, the provider has the difficult task of determining if the patient’s pain is of cardiac or non-cardiac origin. This is a high-stakes decision, as patients discharged with an incorrect diagnosis of non-cardiac chest pain are at high risk for morbidity and mortality, while the provider is at high risk for a medical malpractice claim (Pope et al., N Engl J Med 342(16):1163–1170, 2000; Amsterdam et al., Circulation 122(17):1756–1776, 2010). Diagnostic imaging studies, such as coronary computed tomography angiography, cardiac magnetic resonance imaging, stress echocardiography, and nuclear imaging, play an important role in the risk stratification of patients presenting with chest pain or other symptoms concerning for acute coronary syndrome (ACS). This article will evaluate and summarize the recent evidence relevant to diagnostic imaging modalities used to exclude ACS.
- Published
- 2012
38. Cost analysis of the History, ECG, Age, Risk factors, and initial Troponin (HEART) Pathway randomized control trial
- Author
-
Cedric Lefebvre, Simon A. Mahler, Robert F. Riley, Kim Askew, David M. Cline, Bret A. Nicks, Gregory B. Russell, Brian Hiestand, Chadwick D. Miller, Erin N. Harper, and James W. Hoekstra
- Subjects
Male ,030204 cardiovascular system & hematology ,Chest pain ,law.invention ,Electrocardiography ,0302 clinical medicine ,Randomized controlled trial ,Clinical Protocols ,law ,Risk Factors ,Health care ,Medicine ,Myocardial infarction ,Medical History Taking ,Early discharge ,Referral and Consultation ,health care economics and organizations ,Randomized Controlled Trials as Topic ,medicine.diagnostic_test ,Age Factors ,General Medicine ,Health Care Costs ,Middle Aged ,Troponin ,Emergency Medicine ,Costs and Cost Analysis ,Female ,medicine.symptom ,Emergency Service, Hospital ,Adult ,medicine.medical_specialty ,Acute coronary syndrome ,Chest Pain ,Cardiology ,Risk Assessment ,Decision Support Techniques ,03 medical and health sciences ,Cost Savings ,Humans ,Acute Coronary Syndrome ,Intensive care medicine ,Aged ,business.industry ,030208 emergency & critical care medicine ,Emergency department ,medicine.disease ,United States ,Emergency medicine ,Exercise Test ,business - Abstract
Introduction The HEART Pathway is a diagnostic protocol designed to identify low-risk patients presenting to the emergency department with chest pain that are safe for early discharge. This protocol has been shown to significantly decrease health care resource utilization compared with usual care. However, the impact of the HEART Pathway on the cost of care has yet to be reported. Methods and Results We performed a cost analysis of patients enrolled in the HEART Pathway trial, which randomized participants to either usual care or the HEART Pathway protocol. For low-risk patients, the HEART Pathway recommended early discharge from the emergency department without further testing. We compared index visit cost, cost at 30 days, and cardiac-related health care cost at 30 days between the 2 treatment arms. Costs for each patient included facility and professional costs. Cost at 30 days included total inpatient and outpatient costs, including the index encounter, regardless of etiology. Cardiac-related health care cost at 30 days included the index encounter and costs adjudicated to be cardiac-related within that period. Two hundred seventy of the 282 patients enrolled in the trial had cost data available for analysis. There was a significant reduction in cost for the HEART Pathway group at 30 days (median cost savings of $216 per individual), which was most evident in low-risk (Thrombolysis In Myocardial Infarction score of 0-1) patients (median savings of $253 per patient) and driven primarily by lower cardiac diagnostic costs in the HEART Pathway group. Conclusions Using the HEART Pathway as a decision aid for patients with undifferentiated chest pain resulted in significant cost savings.
- Published
- 2016
39. Chest Pain Risk Stratification: A Comparison of the 2-Hour Accelerated Diagnostic Protocol (ADAPT) and the HEART Pathway
- Author
-
Greg L. Burke, Kim Askew, Robert F. Riley, David M. Herrington, Brian Hiestand, David M. Cline, Cedric Lefebvre, Bret A. Nicks, Chadwick D. Miller, Jason P. Stopyra, Gregory B. Russell, Simon A. Mahler, and James W. Hoekstra
- Subjects
Diagnostic Imaging ,Male ,medicine.medical_specialty ,Acute coronary syndrome ,Chest Pain ,Decision Making ,030204 cardiovascular system & hematology ,Chest pain ,Risk Assessment ,Severity of Illness Index ,Article ,Diagnosis, Differential ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Internal medicine ,medicine ,North Carolina ,Humans ,cardiovascular diseases ,Myocardial infarction ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Incidence ,Reproducibility of Results ,030208 emergency & critical care medicine ,Retrospective cohort study ,Emergency department ,Middle Aged ,medicine.disease ,Troponin ,Surgery ,Survival Rate ,Cardiology ,Critical Pathways ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,Emergency Service, Hospital ,Mace ,Follow-Up Studies - Abstract
Background: The 2-hour accelerated diagnostic protocol (ADAPT) and the history electrocardiogram age risk factors troponin (HEART) Pathway are decision aids designed to identify Emergency Department (ED) patients with chest pain who are safe for early discharge. Both have demonstrated high sensitivity (>99%) for major adverse cardiac events (MACE) at 30 days and early discharge rates ≥20%. The objective of this study is to compare the sensitivity and early discharge rates of the ADAPT and HEART Pathway decision aids in a cohort of ED patients with acute chest pain. Methods: A secondary analysis of participants enrolled and randomized to the HEART Pathway arm of the HEART pathway randomized controlled trial was conducted. Each patient was prospectively classified as low risk (suitable for early discharge) or high risk by ADAPT and the HEART Pathway. Sensitivity for MACE at 30 days and the number of patients identified as low-risk were calculated for each decision aid. Decision aid performance was compared using McNemar’s test. Results: MACE occurred in 8 of 141 (5.7%); there were no deaths, 7 patients had myocardial infarction, and 1 patient had coronary revascularization without myocardial infarction. ADAPT and the HEART pathway identified all patients with MACE as high risk; sensitivity for MACE of 100% [95% confidence interval (CI): 63–100%]. ADAPT identified 34 of 141 patients (24%; 95% CI: 17–32%) as low-risk, whereas the Heart pathway identified 66 of 141 patients (47%, 95% CI: 38–55%) as low risk (P Conclusions: Within a cohort of ED patients with acute chest pain, ADAPT and the HEART pathway had high sensitivity for MACE. The HEART pathway outperformed ADAPT by correctly identifying more patients as low risk and safe for early discharge.
- Published
- 2016
40. HEART Pathway Accelerated Diagnostic Protocol Implementation: Prospective Pre-Post Interrupted Time Series Design and Methods
- Author
-
Chadwick D. Miller, Gregory L. Burke, Larry D Case, Simon A. Mahler, Brian Hiestand, Robert F. Riley, Pamela W. Duncan, David M. Herrington, and Brian J. Wells
- Subjects
Acute coronary syndrome ,chest pain ,030204 cardiovascular system & hematology ,Chest pain ,Interrupted Time Series Analysis ,acute coronary syndrome ,03 medical and health sciences ,0302 clinical medicine ,Acute chest pain ,Protocol ,electronic medical records ,Medicine ,030212 general & internal medicine ,interrupted time series analysis ,Protocol (science) ,Original Paper ,business.industry ,Medical record ,Interrupted time series ,General Medicine ,medicine.disease ,decision support technique ,3. Good health ,implementation methods ,Healthcare utilization ,Medical emergency ,medicine.symptom ,business - Abstract
Background Most patients presenting to US Emergency Departments (ED) with chest pain are hospitalized for comprehensive testing. These evaluations cost the US health system >$10 billion annually, but have a diagnostic yield for acute coronary syndrome (ACS) of 5000 patient encounters. The HEART Pathway has been fully integrated into health system electronic medical records, providing real-time decision support to our providers. Conclusions We hypothesize that the HEART Pathway will safely reduce healthcare utilization. This study could provide a model for delivering high-value care to the 8-10 million US ED patients with acute chest pain each year. ClinicalTrial Clinicaltrials.gov NCT02056964; https://clinicaltrials.gov/ct2/show/NCT02056964 (Archived by WebCite at http://www.webcitation.org/6ccajsgyu)
- Published
- 2016
41. Cholesteryl Esters Associated With Acyl-CoA:cholesterol Acyltransferase Predict Coronary Artery Disease in Patients With Symptoms of Acute Coronary Syndrome
- Author
-
Michael J. Thomas, Chadwick D. Miller, Martha D. Wilson, Janet K. Sawyer, Brian Hiestand, Michael P. Samuel, and Lawrence L. Rudel
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,medicine.diagnostic_test ,business.industry ,General Medicine ,Chest pain ,medicine.disease ,Coronary artery disease ,chemistry.chemical_compound ,chemistry ,Interquartile range ,Internal medicine ,Angiography ,Emergency Medicine ,medicine ,Cardiology ,Cholesteryl ester ,Radiology ,Myocardial infarction ,medicine.symptom ,business ,Prospective cohort study - Abstract
ACADEMIC EMERGENCY MEDICINE 2012; 19:673–682 © 2012 by the Society for Academic Emergency Medicine Abstract Objectives: Identifying the likelihood of a patient having coronary artery disease (CAD) at the time of emergency department (ED) presentation with chest pain could reduce the need for stress testing or coronary imaging after myocardial infarction (MI) has been excluded. The authors aimed to determine if a novel cardiac biomarker consisting of plasma cholesteryl ester (CE) levels typically derived from the activity of the enzyme acyl-CoA:cholesterol acyltransferase (ACAT2) are predictive of CAD in a clinical model. Methods: A single-center prospective cohort design enrolled participants with symptoms of acute coronary syndrome (ACS) undergoing coronary computed tomography angiography (CCTA) or invasive angiography. Plasma samples were analyzed for CE composition with mass spectrometry. The primary endpoint was any CAD determined at angiography. Multivariable logistic regression analyses were used to estimate the relationship between the sum of the plasma concentrations from cholesteryl palmitoleate (16:1) and cholesteryl oleate (18:1) (defined as ACAT2-CE) and the presence of CAD. The added value of ACAT2-CE to the model was analyzed comparing the C-statistics and integrated discrimination improvement (IDI). Results: The study cohort was composed of 113 participants with a mean (± standard deviation [SD]) age of 49 (±11.7) years, 59% had CAD at angiography, and 23% had an MI within 30 days. The median (interquartile range [IQR]) plasma concentration of ACAT2-CE was 938 μmol/L (IQR = 758 to 1,099 μmol/L) in patients with CAD and 824 μmol/L (IQR = 683 to 998 μmol/L) in patients without CAD (p = 0.03). When considered with age, sex, and the number of conventional CAD risk factors, ACAT2-CE levels were associated with a 6.5% increased odds of having CAD per 10 μmol/L increase in concentration. The addition of ACAT2-CE significantly improved the C-statistic (0.89 vs. 0.95, p = 0.0035) and IDI (0.15, p
- Published
- 2012
42. Implications of 25% to 50% coronary stenosis with cardiac computed tomographic angiography in ED patients
- Author
-
Kim Askew, Anna Marie Chang, Harold Litt, Benjamin Weisenthal, Judd E. Hollander, Chadwick D. Miller, J. Jeffrey Carr, Daniel W. Entrikin, and Jane Kilkenny
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,medicine.medical_treatment ,Myocardial Infarction ,Coronary Angiography ,Chest pain ,Severity of Illness Index ,Electrocardiography ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,Acute Coronary Syndrome ,Retrospective Studies ,Cardiac catheterization ,Framingham Risk Score ,Tomography, X-Ray ,business.industry ,Unstable angina ,Coronary Stenosis ,General Medicine ,Middle Aged ,medicine.disease ,Stenosis ,Emergency Medicine ,Cardiology ,Female ,Radiology ,medicine.symptom ,Emergency Service, Hospital ,business ,Mace - Abstract
Objective The aim of this study was to determine if patients presenting with symptoms of acute coronary syndrome and found to have 25% to 50% diameter reduction with coronary computed tomographic angiography (CCTA) are likely to benefit from further diagnostic testing. Methods A registry study of 213 subjects (median age, 51 years; 53% women) with symptoms concerning for possible acute coronary syndrome with low-risk features found to have 25% to 50% maximal diameter stenosis on CCTA was performed at 2 academic medical centers. The analysis was approved by an institutional review board and was conducted with waiver of consent. The potential contribution of additional testing was determined by measuring the major adverse cardiac events (MACEs) from presentation through 30 days. The MACEs included myocardial infarction, coronary revascularization, unstable angina, and cardiovascular death. Sample size calculations were predicated on a 0% MACE rate leading to upper bounds of a 2-sided exact 95% confidence interval less than 2%. Results Thrombolysis in myocardial infarction risk score of less than 2 was present in 92% subjects, 70% (150 of 213) had 2 or more serial cardiac markers performed, and 40% (87 of 213) had stress testing or cardiac catheterization. The MACEs occurred in 1 (0.5%) of 213 subjects (95% confidence interval, 0%-2.6%) and was identified by an elevation of serial cardiac markers during the index hospitalization. No patients experienced cardiovascular death or required revascularization. Conclusions In patients with emergent low-risk chest pain and 25% to 50% diameter coronary stenosis by CCTA, the rate of near-term MACE is very low. Serial cardiac markers may be beneficial in this subgroup. Routine provocative testing is unlikely to be beneficial during the index visit.
- Published
- 2012
43. Building a Better Mousetrap for Chest Pain
- Author
-
Chadwick D. Miller, Brigitte M. Baumann, and David C. Cone
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,business.industry ,Diagnostic test ,General Medicine ,Chest pain ,medicine.disease ,Copeptin ,Troponin I ,Emergency Medicine ,medicine ,Biomarker (medicine) ,Myocardial infarction ,medicine.symptom ,Intensive care medicine ,business - Abstract
This commentary discusses two articles in the current issue of Academic Emergency Medicine that report on investigations of copeptin, a novel biomarker used in conjunction with troponin and an accelerated diagnostic protocol (ADP) in the evaluation of chest pain patients. The authors discuss the challenges and future directions of the evaluation and identification of low-risk chest pain patients who are safe for discharge without additional diagnostic testing.
- Published
- 2012
44. Regional Patterns of Use of a Medical Management Strategy for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
- Author
-
Charles V. Pollack, Robert A. Harrington, Padma Kaul, Gilles Montalescot, Robert M. Califf, Judith S. Hochman, Jorge F. Saucedo, Stefan James, E. Magnus Ohman, Yuliya Lokhnygina, Arnoud W. van't Hof, Matthew T. Roe, Frans Van de Werf, Pierluigi Tricoci, Chadwick D. Miller, Paul W. Armstrong, L. Kristin Newby, Jennifer A. White, and Robert P. Giugliano
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,Platelet Glycoprotein GPIIb-IIIa Complex ,Coronary Angiography ,Coronary artery disease ,Electrocardiography ,Internal medicine ,medicine ,Humans ,ST segment ,Acute Coronary Syndrome ,Coronary Artery Bypass ,Aged ,medicine.diagnostic_test ,biology ,business.industry ,Mortality rate ,Middle Aged ,medicine.disease ,Troponin ,Clinical trial ,Angiography ,biology.protein ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Platelet Aggregation Inhibitors - Abstract
Background— Regional differences in the profile and prognosis of non–ST-segment elevation acute coronary syndrome (NSTE ACS) patients treated with medical management after angiography remain uncertain. Methods and Results— Using data from the Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS) trial, we examined regional variations in the use of an in-hospital medical management strategy in NSTE ACS patients who had significant coronary artery disease (CAD) identified during angiography, factors associated with the use of a medical management strategy, and 1-year mortality rates. Of 9406 patients, 8387 (89%) underwent angiography and had significant CAD; thereafter, 1766 (21%) were treated solely with a medical management strategy (range: 18% to 23% across 4 major geographic regions). Factors most strongly associated with a medical management strategy were negative baseline troponin values, prior coronary artery bypass grafting, lower baseline hemoglobin values, and greater number of diseased vessels; region was not a significant factor. One-year mortality was higher among patients treated with a medical management strategy compared with those who underwent revascularization (7.8% versus 3.6%; adjusted hazard ratio, 1.46; 95% CI, 1.21–1.76), with no significant interaction by region (interaction probability value=0.42). Conclusions— Approximately 20% of NSTE ACS patients with significant CAD in an international trial were treated solely with an in-hospital medical management strategy after early angiography, with no regional differences in factors associated with medical management or the risk of 1-year mortality. These findings have important implications for the conduct of future clinical trials, and highlight global similarities in the profile and prognosis of medically managed NSTE ACS patients. Clinical Trial Registration— URL: www.clinicaltrials.gov . Unique identifier: NCT00089895.
- Published
- 2012
45. Cardiac Magnetic Resonance in the Emergency Department to Evaluate Patients for Possible Acute Coronary Syndrome
- Author
-
Chadwick D. Miller and W. Gregory Hundley
- Subjects
Acute coronary syndrome ,medicine.medical_specialty ,Histology ,medicine.diagnostic_test ,business.industry ,Cost effectiveness ,Stress testing ,Ultrasound ,Interventional radiology ,Cell Biology ,Emergency department ,medicine.disease ,Chest pain ,Applied Microbiology and Biotechnology ,Internal medicine ,Edema ,medicine ,Cardiology ,Radiology ,medicine.symptom ,business - Abstract
The use of cardiac magnetic resonance (CMR) imaging has recently been demonstrated to be a useful adjunct in the evaluation of emergency department (ED) patients with acute chest pain. This modality allows the assessment of non-ischemic causes of chest pain, early ischemic changes (T2-weighted imaging for edema), resting and stress perfusion abnormalities, resting and stress wall motion abnormalities, and assessment for scar formation with delayed enhancement. This comprehensive information appears most useful when evaluating higher complexity patients such as those at intermediate or high risk for ACS. In these more complex patients, the use of CMR is supported by appropriateness criteria, and in recent studies appears to be a cost-effective alternative to inpatient evaluation when combined with observation unit care.
- Published
- 2012
46. Myeloperoxidase in the diagnosis of acute coronary syndromes: The importance of spectrum
- Author
-
Abhinav Chandra, John T. Nagurney, Vance Wong, Robert H. Birkhahn, Richard M. Nowak, Judd E. Hollander, Chadwick D. Miller, Deborah B. Diercks, James Neuenschwander, Ken Kupfer, Elizabeth Lee Lewandrowski, Stephen Plantholt, Francis L. Counselman, Nathan I. Shapiro, Joshua M. Kosowsky, Adam J. Singer, Ted Glynn, Basmah Safdar, W. Frank Peacock, Jon W. Schrock, and Mary Ann Peberdy
- Subjects
Male ,Risk ,medicine.medical_specialty ,Acute coronary syndrome ,Diagnostic Techniques, Cardiovascular ,Sensitivity and Specificity ,Likelihood ratios in diagnostic testing ,Angina Pectoris ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Myocardial infarction ,Acute Coronary Syndrome ,Prospective cohort study ,Aged ,Peroxidase ,biology ,business.industry ,Unstable angina ,Troponin I ,Emergency department ,Middle Aged ,medicine.disease ,United States ,Surgery ,ROC Curve ,Predictive value of tests ,Myeloperoxidase ,Cardiology ,biology.protein ,Female ,Emergency Service, Hospital ,Cardiology and Cardiovascular Medicine ,business - Abstract
Myeloperoxidase (MPO) is proposed for risk stratification in patients with suspected acute coronary syndromes (ACSs). We determined if MPO has diagnostic value in patients being evaluated for ACS.MIDAS was an 18-center prospective study enrolling suspected ACS emergency department patients who presented8 hours after symptom onset and in whom serial cardiac markers and objective cardiac perfusion testing were planned. Blinded MPO (Biosite, Inc, San Diego, CA) and troponin I (Triage Cardio 3; Biosite, Inc) were drawn at arrival, and Troponin I (TnI) was measured at 90, 180, and 360 minutes. Final diagnoses were adjudicated by the local investigator blinded to study assay.Of 1,018 patients, 54% were male, 26% black, with a mean age of 58 ± 13 years. Diagnoses were ACS in 288 (23%) and noncardiac chest pain (NCCP) in 788 (77%). Of patients with ACS, 94 (9.2%) had a myocardial infarction (MI) at presentation (69 non-ST-elevation MI, 25 ST-elevation MI), and 136 had unstable angina. Using a cutpoint of 210 ng/mL to provide 90% specificity, MPO had a sensitivity of 0.18; negative predictive value, 0.69; positive predictive value, 0.47; negative likelihood ratio, 0.91; and a positive likelihood ratio of 1.83 to differentiate ACS and NCCP. Because of the large overlap of quartiles, MPO was not clinically useful to predict serial TnI changes. The C statistics ± 95% CI for MPO differentiating ACS from NCCP and for AMI versus NCCP were 0.629 ± 0.04 and 0.666 ± 0.06, respectively.Myeloperoxidase has insufficient accuracy for decision making in patients with suspected ACS.
- Published
- 2011
47. Can the HEART Score Safely Reduce Stress Testing and Cardiac Imaging in Patients at Low Risk for Major Adverse Cardiac Events?
- Author
-
David C. Goff, Chadwick D. Miller, James W. Hoekstra, Simon A. Mahler, and Brian Hiestand
- Subjects
medicine.medical_specialty ,Acute coronary syndrome ,medicine.diagnostic_test ,business.industry ,Stress testing ,Retrospective cohort study ,Chest pain ,medicine.disease ,Internal medicine ,medicine ,Cardiology ,Cardiac Imaging Techniques ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,Electrocardiography ,Cardiac imaging - Abstract
Background Patients with low risk chest pain have high utilization of stress testing and cardiac imaging, but low rates of acute coronary syndrome (ACS). The objective of this study was to determine if the HEART score could safely reduce objective cardiac testing in patients with low risk chest pain.
- Published
- 2011
48. Stress CMR Imaging Observation Unit in the Emergency Department Reduces 1-Year Medical Care Costs in Patients With Acute Chest Pain
- Author
-
Craig A. Hamilton, Howard Blumstein, W. Gregory Hundley, James W. Hoekstra, Cedric Lefebvre, Erin N. Harper, Chadwick D. Miller, Wenke Hwang, and Doug Case
- Subjects
medicine.medical_specialty ,Randomization ,030204 cardiovascular system & hematology ,Chest pain ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Myocardial infarction ,Inpatient care ,business.industry ,Emergency department ,medicine.disease ,3. Good health ,Clinical trial ,Radiology Nuclear Medicine and imaging ,Predictive value of tests ,Emergency medicine ,cardiovascular system ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objectives This study sought to compare the direct cost of medical care and clinical events during the first year after patients with intermediate risk acute chest pain were randomized to stress cardiac magnetic resonance (CMR) observation unit (OU) testing versus inpatient care. Background In a recent study, randomization to OU-CMR reduced median index hospitalization cost compared with the cost of inpatient care in patients presenting to the emergency department with intermediate risk acute chest pain. Methods Emergency department patients with intermediate risk chest pain were randomized to OU-CMR (OU care, cardiac markers, stress CMR) or inpatient care (admission, care per admitting provider). This analysis reports the direct cost of cardiac-related care and clinical outcomes (myocardial infarction, revascularization, cardiovascular death) during the first year of follow-up subsequent to discharge. Consistent with health economics literature, provider cost was calculated from work-related relative value units using the Medicare conversion factor; facility charges were converted to cost using departmental-specific cost-to-charge ratios. Linear models were used to compare cost accumulation among study groups. Results We included 109 randomized subjects in this analysis (52 OU-CMR, 57 inpatient care). The median age was 56 years; baseline characteristics were similar in both groups. At 1 year, 6% of OU-CMR and 9% of inpatient care participants experienced a major cardiac event (p = 0.72) with 1 patient in each group experiencing a cardiac event after discharge. First-year cardiac-related costs were significantly lower for participants randomized to OU-CMR than for participants receiving inpatient care (geometric mean = $3,101 vs. $4,742 including the index visit [p = 0.004] and $29 vs. $152 following discharge [p = 0.012]). During the year following randomization, 6% of OU-CMR and 9% of inpatient care participants experienced a major cardiac event (p = 0.72). Conclusions An OU-CMR strategy reduces cardiac-related costs of medical care during the index visit and over the first year subsequent to discharge, without an observed increase in major cardiac events. (Cost Comparison of Cardiac Magnetic Resonance Imaging [MRI] Use in Emergency Department [ED] Patients With Chest Pain; NCT00678639 )
- Published
- 2011
49. Conflicts of Interest in Human Subjects Research: Special Considerations for Academic Emergency Physicians
- Author
-
Shellie Asher, Chadwick D. Miller, and Raquel M. Schears
- Subjects
medicine.medical_specialty ,Medical education ,Virtue ,business.industry ,media_common.quotation_subject ,Conflict of interest ,Alternative medicine ,Ethics committee ,General Medicine ,Emergency department ,Discount points ,Session (web analytics) ,Family medicine ,Emergency Medicine ,medicine ,business ,media_common - Abstract
Trust in the doctor-patient or investigator-subject relationship is vital to the practice of medicine and advancement through biomedical research. Individual and environmental factors can make this trust more difficult to establish in the emergency department (ED). To perform research ethically and maintain this trust, it is important to minimize and manage conflicts of interest in human subjects research. While principle-based ethics are an important starting point, the virtue of the individual investigator is required to assure that the interests and safety of research participants are prioritized over the interests of the investigator or the medical community at large. SAEM Ethics Committee 2009-2010 Objective 4: "Based on the results of the didactic session presented at the annual meeting, develop a guide to assist SAEM members in the recognition of potential conflicts of interest in the practice of academic emergency medicine".
- Published
- 2011
50. Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency Department
- Author
-
Brian Hiestand, Donald Schreiber, Robert C. Pendleton, Samuel Z. Goldhaber, James R. Thompson, David E. Slattery, Chadwick D. Miller, Jeffrey A. Kline, John Fanikos, Beau Briese, Charles V. Pollack, and Brian J. O'Neil
- Subjects
education.field_of_study ,medicine.medical_specialty ,business.industry ,Mortality rate ,Population ,Emergency department ,medicine.disease ,Pulmonary embolism ,Informed consent ,Epidemiology ,Emergency medicine ,Medicine ,business ,education ,Prospective cohort study ,Cardiology and Cardiovascular Medicine ,Fibrinolytic agent - Abstract
Objectives In a large U.S. sample, this study measured the presentation features, testing, treatment strategies, and outcomes of patients diagnosed with pulmonary embolism (PE) in the emergency department (ED). Background No data have quantified the demographics, clinical features, management, and outcomes of outpatients diagnosed with PE in the ED in a large, multicenter U.S. study. Methods Patients of any hemodynamic status were enrolled from the ED after confirmed acute PE or with a high clinical suspicion prompting anticoagulation before imaging for PE. Exclusions were inability to provide informed consent (where required) or unavailability for follow-up. Results A total of 1,880 patients with confirmed acute PE were enrolled from 22 U.S. EDs. Diagnosis of PE was based upon positive results of computerized tomographic pulmonary angiogram in most cases (n = 1,654 [88%]). Patients represented both sexes equally, and racial and ethnic composition paralleled the overall U.S. ED population. Most (79%) patients with PE were employed, and one-third were older than age 65 years. The mortality rate directly attributed to PE was 20 in 1,880 (1%; 95% confidence interval [CI]: 0% to 1.6%). Mortality from hemorrhage was 0.2%, and the all-cause 30-day mortality rate was 5.4% (95% CI: 4.4% to 6.6%). Only 3 of 20 patients with major PE that ultimately proved fatal had systemic anticoagulation initiated before diagnostic confirmation, and another 3 of these 20 received a fibrinolytic agent. Conclusions Patients diagnosed with acute PE in U.S. EDs have high functional status, and their mortality rate is low. These registry data suggest that appropriate initial medical management of ED patients with severe PE with anticoagulation is poorly standardized and indicate a need for research to determine the appropriate threshold for empiric treatment when PE is suspected before diagnostic confirmation.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.